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1. Introduction 
 
1.1      Aging and Longevity Processes 
 
1.1.1.  Biodemography of Human Aging 
Human senescence has been delayed by a decade. Most western countries 
have experienced large increases in mean life expectancy, from around 50 
years to around 75–80 years. This has been due to a marked reduction in 
early life mortality during the first half of the twentieth century, followed by 
a almost twofold reduction in mortality at ages above 70 in the past 50 years 
(Vaupel et al., 1998). This finding is a fundamental discovery about the 
biology of human aging, and will have profound implications for individuals, 
society and the economy. Remarkably, the rate of deterioration with age 
seems to be constant across individuals and over time: it seems that death is 
being delayed because people are reaching old age in better health. 
Research by demographers, epidemiologists and other biomedical 
researchers suggests that further progress is likely to be made in advancing 
the frontier of survival — and healthy survival — to even greater ages. 
Mortality has been postponed considerably, as a result not of revolutionary 
advances in slowing the process of aging but of ongoing progress in 
improving health. The debility that often characterizes the last years of life 
also seems to have been delayed, although the evidence is mixed, in part 
because deterioration is difficult to define and measure.  
Due to the improvement of health care and to a more correct life style it 
seems plausible that very long lives may be the probable destiny of younger 
people alive today. If progress in reducing mortality continues at the same 
pace as it has over the past two centuries then, in countries with high life 
expectancies most children born since the year 2000 will celebrate their 
100th birthday — in the twenty-second century. These longer life spans will 
alter the way individuals want to allocate time during their lives and will 
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require drastic revision of employment, retirement, health, education and 
other policies.  
Biological, epidemiologic, and demographic data have generated a number 
of theories that attempt to identify the cause and the process to explain 
aging and its inevitable consequence, death. These theories have been 
grouped by Weinert into several categories on the basis of levels of 
organization they affect (molecular, cellular, systemic and evolutionary) 
(Table I). In complex, multi-cellular organisms and particularly in humans, 
the study of interactions among intrinsic (genetic), extrinsic 
(environmental), and stochastic (random damage to vital molecules) factors 
provides a fruitful approach conducive to a comprehensive and realistic 
understanding of the aging process.  
 
Table I. Classification and brief description of main theories of aging 
Biological Level/Theory Description 
Evolutionary  
  Mutation accumulation Mutation that affect health at older ages are not selected against. 
  Disposable soma Somatic cells are maintained  only to ensure continued reproductive       
success; after reproduction soma becomes disposable soma. 
  Antagonistic pleiotropy 
Genes beneficial at younger age become deleterious at older ages. 
Molecular  
  Gene regulation Aging is caused by changes in the expression of genes regulating both 
development and aging. 
  Codon restriction Fidelity/accuracy of m RNA translation is impaired due to inability to 
decode codons in m RNA 
  Error catastrophe Decline in fidelity of gene expression with aging results in increased 
fraction of abnormal proteins. 
  Somatic mutation Molecular damage accumulate, primarily to DNA /genetic material. 
  Dysdifferentiation Gradual accumulation of random molecular damage impairs 
regulation of  gene expression. 
Cellular  
  Cellular senescence-Telomere theory Phenotypes of aging are caused by an increase in frequency of 
senescent cells. Senescence may result from telomere loss (replicative 
senescence) or cell stress (cellular senescence).  
  Free radical Oxidative metabolism produces highly reactive free radicals that 
subsequently damage lipids, protein and DNA. 
  Wear-and-tear Accumulation of normal injury. 
  Apoptosis Programmed cell death from genetic events or genome crisis. 
System  
  Neuroendocrine Alteration in neuroendocrine control of homeostasis results in aging-
related physiological changes. 
  Immunologic Decline of immune function with aging results in decrease incidence of 
infectious diseases but increased incidence of autoimmunity. 
  Rate-of-living Assumes a fixed amount of metabolic potential for every living 
organism (live fast, die young). 
 
 
Table I. Classification and brief description of main theories of aging by Weinert et al.2003 
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A major contribution of biodemography researcher has been to show greater 
variation in patterns of aging, including so-called inverse senescence — the 
decline of mortality and the improvement of health over all or most of adult 
life  (Baudisch A., 2008) 
A number of  studies confirm that, for some species and some periods of 
adult life, mortality can decline with age and that changes in diet and other 
environmental factors, as well as genetic changes, can greatly alter age 
trajectories of survival. (Finch C. E., 1990; Rose M. R., 1994). 
 
1.1.2. Progress in delaying debility 
In contrast with death, health is difficult to measure and is often unreliably 
reported. The prevalence of diseases and morbid disorders among the 
elderly has tended to increase over time. In part this rise may be due to 
earlier diagnosis of, for example, type 2 diabetes, hypertension and some 
cancers. Moreover, aged individuals are more often reported to have 
multiple disorders. Disability is usually measured in terms of self-reported 
limitations concerning activities of daily living, such as dressing, bathing, 
shopping and so on. There is increasing evidence that the prevalence of 
disability may be decreasing (Christensen et al., 2009) reflecting better 
treatment and a postponement of senescence, but some studies find an 
increase in the prevalence of disability (Jagger et al., 2008; Parker et al., 
2008). The prevalence of a disease or condition depends on the net balance 
between death and incidence, with death delayed by more effective 
treatment and with incidence increased not only by the greater frequency of 
the condition but also by improved screening. Three states of health can be 
distinguished: a person can be healthy, unhealthy or dead. To the extent 
that the unhealthy state is better than death, greater prevalence of 
morbidity among the elderly may be a positive development. The unhealthy 
state can be broken down into two states: having a chronic illness but being 
able to function, and being disabled. Although it does not reduce morbidity, 
effective rehabilitation reduces disability. Suffering from erratic heart 
rhythms but controlling them with a pacemaker, or suffering a stroke but 
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getting physical therapy, increases the prevalence of morbidity but is 
preferable to being incapacitated by illness, or death. Research on which 
countries are doing best in minimizing disability — and how — could 
greatly benefit the elderly.  
With rising age, women make up an increasing share of the population 
(Passarino et al., 2002). In terms of various indices of health and disability, 
however, older men generally do better than coeval women. This is the 
health–survival paradox: men seem to be healthier than women, but they 
die younger (Oksuzyan et al., 2008). Social and biological factors interact to 
determine the prevalence of frail females and dead males, but the relative 
importance of specific mechanisms is not well understood (Austad S., 2006). 
Males tend to believe their health is better than it actually is and do not 
seek medical care as frequently as females: they have fewer appointments 
with general practitioners but require emergency treatment more often. 
Females seem to be better able to survive with poor health. Males tend to 
engage in reckless behavior. This tendency may be partly genetic in origin, 
having its basis in the different reproductive opportunities males face in 
comparison with females (Bonduriansky et al., 2008). 
Lastly, to achieve life expectancies of 100 years or more, new knowledge will 
be needed. Research advances suggest that cardiovascular diseases, CVD, 
and malignant neoplasms will be prevented and treated much more 
effectively in the future. Two scourges of senescence are cognitive 
impairment, often due to Alzheimer‘s disease, and sensory deprivation. 
Progress in overcoming these scourges would greatly enhance old age. 
Genetics research, both in humans and in non-human species, will 
contribute to a deeper understanding of the mechanisms that cause 
senescence and may allow individualized medical treatment based on 
knowledge of individuals‘ genomes. Research on non-genetic interventions 
like dietary restriction  (Mair et al., 2003) and other might also lead to 
strategies for delaying human aging. The emerging field of regenerative 
medicine shows great promise, and in the next decades it might be possible 
to rejuvenate organs and tissues. Nanotechnologies also might have a role in 
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postponing senescence. Priority research include study not only of very long 
lived subjects such as nonagenarians, centenarians and supercentenarians, 
but especially on family longevity , on male versus female health and 
survival, on how improvements in health and reductions in mortality in the 
young and the middle aged influence health and mortality in old age. 
(Vaupel, 2010).  
 
1.2. Genetic Determinants of human longevity 
1.2.1. Insights from model organisms 
Lifespan is the outcome of complicated processes that might involve 
thousands of genes and non-genetic factors. Findings from animal studies 
have provided evidence that individual genes can have a significant effect on 
lifespan. Furthermore, human genetic studies have shown that common 
polymorphisms in one gene — apolipoprotein E (APOE) — influence 
lifespan, probably mainly through their association with disease. (Corder et 
al., 1996). Due to their short lifespan and the ability to control both 
environment and genotype invertebrate animal models have been largely 
used for studying genetic variants associated with longevity. 
Several general facts about the biology of longevity have become clear from 
animal models: most of  the genes involved are pleiotropic, specify increased 
stress resistance and result in increased robustness in older animals. 
Animal studies have also revealed a down side to increased lifespan: many 
long-lived mutants are slow-growing, with reduced fecundity and fertility, 
and fail to compete in a changing environment (Walker et al., 2000). Animal 
studies have also provided insights into the types of gene that can be 
involved in the regulation of lifespan. The first longevity mutant to be 
identified was the C. elegans gene age-1 (Friedman et al., 1988) that 
encodes phosphatidylinositol 3-kinase (PI3K) (Ogg et al., 1997), which has a 
key role in a signaling pathway that is homologous to the mammalian 
insulin–IGF1 (insulin-like growth factor 1) pathway which regulates the 
expression of numerous downstream genes that mediate stress resistance, 
innate immunity, metabolic processes and toxin degradation  (McElwee et 
8 
 
al.,  2003; Murphy et al., 2003). Mutations that affect this pathway show 
notable effects on longevity in both invertebrates and mammals; several 
mouse longevity mutants alter key components of the insulin–IGF1 
pathway, with one of the strongest lines of evidence being the increased 
lifespan of mice that are heterozygous for the IGF1 receptor knockout (Tatar 
et al., 2003). Longevity genes have also been identified in other animal 
models. Two key examples are sir-2 and Tor (Target of rapamycin), which 
were identified in yeast and Drosophila melanogaster, respectively. sir-2 
encodes an NAD-dependent protein deacetylase, which might mediate the 
lifespan-extending effects of dietary restriction, whereas Tor encodes a 
protein that is involved in sensing amino-acid availability. The effects of 
these genes on lifespan indicate a link between nutrient intake and 
longevity, and both genes might be involved in the life-extension effects that 
are mediated by dietary restriction. Importantly, animal studies have shown 
that mortality is affected at some ages but not all (Johnson et al., 2001) so 
human longevity genes might also be age-specific. 
 
Figure I. Schematic representation of molecular pathways lengthening lifespan in 
C. elegans and in humans 
 
 
Figure I. Some of the molecular pathways that lengthen lifespan in 
Caenorhabditis elegans and the corresponding components in humans. 
The C. elegans insulin–IGF-1 (insulin-like growth factor 1) like signal 
transduction pathway is shown on the left, and human homologues of 
the proteins that are involved are shown on the right. This pathway 
involves a cascade of phosphorylation events that ultimately regulate 
the nuclear translocation of DAF-16. INS-N is an unknown insulin-like 
peptide, and DAF-2 is its cell-surface receptor, which has tyrosine 
kinase activity. AGE-1 encodes a phosphatidylinositol 3-kinase (PI3K). 
IP3 is phosphatidylinositol-3,4,5-trisphosphate (for simplicity, it is 
shown here as part of the pathway, although it is actually a membrane 
component), which is produced as a result of AGE-1 activity and 
activates PDK-1. PTEN is a phosphatase with IP3 substrate activity 
and suppresses AGE-1. PDK-1 is an IP3-dependent kinase that 
activates AKT-1, AKT-2 and SGK-1, which are serine/threonine 
kinases. DAF-16 is a forkhead class transcription factor that is 
homologous to the FOXO class of human transcription factors, and is 
probably orthologous to human FOXO3A. The target of rapamycin 
(TOR), JNK and RAS pathways also feed into the insulin-like 
signalling pathway at the level of DAF-16 regulation. TOR is a kinase 
that responds to intracellular amino acids, especially leucine, among 
other activities; RAS and JNK are involved in numerous signal-
transductioncascades in mammals. Numerous other genes in which 
mutations lead to life extension in C. elegans (for example, sir-2 and 
mitochondrial genes) are not shown. 
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1.2.2. Human lifespan as a heritable trait 
A striking and consistent series of epidemiological data from different 
populations (White Americans from New England, Mormons from Utah, 
Ashkenazi Jewish living in the United States, Icelanders, Japanese from 
Okinawa, Netherlanders from Leiden, Danish collected in the entire nation, 
Italians from Southern Italy) suggests the presence of a strong familiar 
component of human longevity. 
1.2.2.1. Twin studies  
Studying twins is of extraordinary interest because they share the same 
genetic background. 
These studies have consistently found that for cohorts born around 100 
years ago, approximately 25% of the variation in lifespan is caused by 
genetic differences (Herskind et al., 1996). Recent combined analyses of 
~20,000 twins born in Nordic countries between 1870 and 1910 confirm this, 
but they also show that the genetic influences on lifespan are minimal 
before the age of 60 and only increase after that age. This finding provides 
support for the search or genes that affect longevity in humans, especially at 
advanced ages (Hjelmborg et al., 2006). Countries with larger socio-
economic differences might be expected to have lower heritability estimates 
owing to larger environmental variance. In terms of frailty, it was estimated 
that the heritability of this trait is approximately 50% (Iachine et al., 1998). 
The model indicates that the importance of survival attributes might 
increase with life expectancy. 
1.2.2.2. Siblings of centenarians 
These subjects have an advantage for survival and for attaining extreme 
longevity. Perls et al., found that the chances of survival until 80–94 years 
old for siblings of centenarians were about four times as high as those for 
siblings of individuals who died at 73 years of age (Perls et al., 2002). From 
the analysis of the pedigrees of 348 Okinawan centenarian families with 
1142 siblings it resulted that both male and female centenarian siblings 
experienced approximately half mortality of their birth cohort-matched 
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counterparts of the general Okinawan population.  (Willcox et al., 2006). 
Moreover, in families with at least two long-living siblings (men aged 89 
years or more and women aged 91 years or more), the rest of their siblings, 
their parents, and their offspring, but not their spouses (husbands and 
wives), showed a higher survival and a mortality rate for all causes of death 
that was 35% less than in the general population Schoenmaker et al., 2006). 
1.2.2.3. Centenarian‘s Offspring  
Centenarian‘s offspring represent one of the best models to study the 
different components which contribute to human aging and longevity 
without the disadvantages inherent in the study of centenarians (rarity, 
lack of a control group of the same age, presence of frailty due to extreme 
age). In particular, centenarian's offspring appear to undergo an aging 
process "better" than that of subjects of the same age (cohort) born from non 
long-lived parents.  
Centenarian's offspring are on average seventy years old, are more 
numerous than centenarians and it is possible to compare them with a 
demographically-matched control group (subjects matched for age, sex, 
ethnicity, parent year of birth, but born from non long-lived parents) thus 
avoiding cohort effects. As regards centenarians offspring literature data 
indicate that: 
I. Centenarian‘s offspring had a 56% reduced relative prevalence of heart 
disease, a 66% reduced relative prevalence of hypertension, and 59% 
reduced relative prevalence of diabetes and that the median ages of onset 
for coronary heart disease, hypertension, diabetes, and stroke were 
significantly delayed compared with the age-matched controls. Moreover 
centenarians‘ offspring had a significantly lower risk of all-cause 
mortality, of cancer- specific mortality, and of coronary heart disease–
specific mortality. (Dellara et al.,2003; Dellara et al., 2004a; Dellara et 
al., 2004b).  
II. Men and women with fathers who died at age greater than 80 years 
showed a 20–30%  lower risk of mortality from stroke, cardiovascular 
disease, and of all causes of mortality compared with those with fathers 
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whose age of death was  lower than 60 years. A similar reduction was 
found when the age of death of mothers was greater than 85 years 
compared with those lower than 65 years. Furthermore, the risk 
reduction was more evident amongst persons with both parents long-lived 
compared with those with both parents short-lived, especially for death 
from cardiovascular disease (Ikeda et al., 2006).  
III. Offspring of Ashkenazi Jewish centenarians had a favourable lipid profile 
compared with control groups. In particular, female offspring of 
centenarians had significantly higher plasma levels of high density 
lipoprotein-cholesterol, HDL-C, compared with controls, while male 
offspring of centenarians had higher plasma levels of HDL-C, and 
significantly lower low density lipoprotein-cholesterol, LDL-C compared 
with controls. These data suggested that a certain phenotypic lipid profile 
may be transmitted in families and that a favourable lipid profile may 
play a role in longevity (Barzilai et al, 2003).  
IV. Offspring of long-lived parents had significantly lower prevalence of 
hypertension (by 23%), diabetes mellitus (by 50%), heart attacks (by 
60%), and strokes than several age-matched control groups, (Atzmon et 
al., 2004) 
V. Centenarians‘ offspring, after approximately 4 years follow-up, had a 
significantly lower risk of myocardial infarction, of stroke, and of 
developing diabetes mellitus than the referent cohort. Additionally, 
centenarians offspring were significantly less likely to die than the 
referent cohort (Adams et al., 2008). 
12 
 
 
1.3. Aging, Immune System and Inflammation 
 
A functional immune system (IS) is considered vital for the host‘s continued 
survival against the daily onslaught of foreign organisms and pathogens. In 
humans, as well as in many other species, it is becoming recognized that the 
immune system declines with age, a term known as immunosenescence, 
which leads to a higher incidence of infections, neoplasia and autoimmune 
diseases. 
Figure II. The effect of age on the different components of the innate and adaptive 
immune systems. 
 
Figure II. The effect of age on the different components of the innate and adaptive immune systems. From 
Danielle Aw et al., 2006 Abbreviations: CLP, common lymphoid precursor; CMP, common lymphoid progenitor; DHEAS, dehydroepiandrosterone 
sulphate; DN, double negative; DP, double positive; ETP, early thymic progenitors; HSC, haematopoietic stem cell; Ig, immunoglobulin; IFN-c, 
interferon-c; NK, natural killer cell; RAG, recombination activating gene; ROS, reactive oxygen species; SP, single positive; TCR, T-cell receptor. 
 
Investigations now suggest that aging is associated with the increased 
production of pro-inflammatory cytokines by macrophages and fibroblasts 
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for example. Elevated levels of these mediators are believed to be 
responsible for most of the age-associated diseases such as diabetes, 
osteoporosis and atherosclerosis because they all share an inflammatory 
pathogenesis. Termed ‗inflamm-aging‘, it has been hypothesized that as a 
result of constant antigenic challenge, the continual production of 
inflammatory mediators could potentially trigger the onset of associated 
inflammatory diseases resulting detrimental for longevity. (De Martinis et 
al., 2005; Licastro et al., 2005).  Indeed, emerging evidence suggests that the 
balance between pro- and anti-inflammatory cytokines can be used as a 
profile to indicate frailty and mortality in older individuals (van den 
Biggelaar et al., 2004).  
1.3.1.  Inflammatory markers in aging 
Elevations in inflammatory markers have been observed with increasing 
age. The defined risk factors for these modest increases include visceral 
adiposity, lower sex steroid hormones, smoking, depression and periodontal 
disease. Among many of inflammatory markers studied in older adults, IL-6 
is most robustly associated with incidence of diseases, disability and 
mortality. Elevated levels of inflammatory markers are also associated with 
a higher incidence of mobility limitation (Penninx et al., 2004) and subjects 
with higher levels of IL-6 were more likely to develop mobility disability and 
had a greater risk of activities of daily living, ADL, disability (Ferrucci et 
al., 2002). Elevated inflammatory markers may increase the risk of CVD 
(Tracy et al., 1997; Aviles et al., 2003; Cesari et al.,2003; Kalogeropoulos et 
al., 2010). In fact, most studies of cardio vascular disease, CVD and 
inflammation support a link  between the two but it is difficult to infer a 
single causal path. In older adults, cardiovascular risk factors and prevalent 
CVD may help elevate pro-inflammatory markers (Ferrucci et al., 2005). 
This can lead to a cause-and-effect cycle with inflammation stimulating 
CVD and CVD stimulating  inflammation. Chronic low-grade inflammation 
in older adults has been linked  to cognitive decline and dementia, including 
vascular dementia  and Alzheimer‘s disease (Yaffe et al., 2003). 
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Among the acute-phase proteins the C-reactive protein and serum amyloid 
A protein, A-SAA are implicated in several chronic inflammatory diseases. 
In fact, C-reactive protein, produced by the liver in response to elevations in 
IL-6, was reported to be positively correlated with resistin levels in several 
pathophysiological conditions (Axelsson et al., 2006) while A-SAA is 
implicated in several chronic inflammatory diseases, such as amyloidosis, 
atherosclerosis, and rheumatoid arthritis (Zhang et al., 2005). 
Moreover with age, an increases of body fat with a shift from the periphery 
to more central abdominal or visceral location was observed. Adipose tissue 
acts as an active endocrine organ, capable of secreting several cytokines 
including IL-6 and TNF-alpha and adipokines such as adiponectin and 
leptin (Trayhurn and Wood, 2005). Levels of adiponectin are inversely 
correlated with body fat percentage in adults and reduced in metabolic 
conditions while they are increased in the presence of chronic inflammatory 
and autoimmune diseases (Fantuzzi, 2007; Ukkola et al., 2009). In human 
leptin influences energy homeostasis and regulates neuroendocrine function 
primarily in states of energy deficiency. As cytokine leptin affects thymic 
homeostasis and, similar to other proinflammatory cytokines, it promotes 
Th1 cell differentiation and cytokine production (Matarese et al., 2005).  
Recently, several studies showed that resistin may also play a pivotal role in 
inflammation and process of inflammation-related diseases. Resistin 
strongly up-regulated IL-6 and TNF-α in human PBMC via NF-κB pathway 
(Bokarewa et al., 2005). More recently, the inflammatory markers were 
shown to be independently associated with circulating resistin levels in 
patients with chronic kidney disease.  
1.3.2. The impact of advancing age on immunity 
1.3.2.1. Innate immunity  
 
Whereas age-related alterations of the components within the adaptive 
immune system are well documented, detailed analysis of the impact of 
advancing age on the innate immune system remains unresolved. An 
increasing number of studies have suggested that there is a decline in the 
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phagocytic capacity and reduced superoxide anion production in 
macrophages and neutrophils in the aged (Gomez et al., 2005). Other 
features of aged phagocytes include a reduced expression of Toll-like 
receptors on macrophages (Plowden et al., 2004). Regarding natural killer 
(NK) cells, it is reasonable to assume that the clinical manifestation of 
immunosenescence could be in part due to the age-related alteration of NK 
cell number and function because of NK cells play an essential role in 
immunity. The number of NK cells increase with age while regarding their 
function there are still conflict reports (Plackett et al., 2004; Mocchegiani et 
al., 2004; Sansoni et al., 1993). Moreover, different NK-cell subsets 
expanded with age; in particular in the elderly there is an increased 
proportion of the CD56– NK-cell subset; cells which exhibit lower cytolytic 
activity and have a reduced ability to secrete cytokines in comparison to the 
more abundant CD56+ NK-cell subset (Borrego et al., 1999). 
Also the humoral immunity in aged individuals is severely compromised. A 
marked decrease of peripheral B lymphocytes was observed in humans 
during age (Sansoni et al., 1993). In addition, the oligoclonal expansions of B 
cells associated with CD5 expression are known to occur in old individuals 
(Cancro et al., 2003) and to occupy niches, which then cannot be occupied by 
other B cells (Eaton-Bassiri et al., 2000). Many other intrinsic B-cell defects 
have also been reported in aged mice and humans, including reduction of co 
stimulatory molecules, (Zheng et al., 1997) defects in B-cell receptor 
signaling (Whisler et al., 1993) and low immunoglobulin titer and affinity. 
In addition, T-cell/B-cell interactions are known to be disrupted both in aged 
humans (Lazuardi  et al., 2005). Such defects in T-cell helper function, 
which are known to occur during aging, (Rink et al., 1998) significantly 
affect humoral immunity because they are required for germinal centre 
formation and production of soluble factors. 
1.3.2.2. Adaptive immunity 
Of all age-associated changes in the immune system (IS), regression of the 
thymus is the most dramatic, ubiquitous and recognizable. Chronic thymic 
atrophy is now accepted as an ancient and conserved evolutionary process 
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and the impact on immunosenescence along with characterization of the 
stages and mechanisms concerned are under increasing scrutiny. The 
thymus is the primary site of T-cell development capable of generating self-
tolerant, self major histocompatibility complex-restricted, 
immunocompetent T cells, (Miller., 1961). With age, there is a decrease in 
thymic epithelial space and thymic cellularity, collectively called thymic 
involution. In mice, loss of thymic epithelial space is caused by a gross 
reduction in thymus size, (Li et al., 2003) whereas in the human thymus 
there is an increase in perivascular space, which is progressively replaced 
with fat in the aging thymus (Flores et al., 1999; Ostan et al., 2008). Despite 
the reduction in functional thymic area, the aging thymus still demonstrates 
T-cell output, although at decreased rates (Douek et al., 1998). Continual 
persistence of T-cell receptor excision circle-positive (TREC+) T cells, 
representing recent thymic emigrants (RTE), was found in the peripheral 
blood of elderly people being ever less evident with advancing age and in 
particular in centenarians (Jamieson et al., 1999; Nasi et al., 2006). 
1.3.2.3. Age-dependent defects in peripheral T cells 
Surprisingly there is little change in the number of peripheral T cells with age, 
especially given the reduction in thymic output in the aged (Hulstaert et al., 
1994). The size of the peripheral T-cell pool is tightly regulated by several 
variables including homeostatic mechanisms. Both memory and naïve T cells 
undergo homeostatic control and in humans steady-state proliferation 
significantly contributes to the naïve T-cell receptor (TCR) repertoire. (Goronzy 
et al., 2005). It had been presumed that naïve and memory T-cell pools were 
maintained separately with different survival requirements that are 
considerably stricter for naïve T cells. (Tanchot et al., 1997). Yet an innovative 
study revealed that clonal expansion of CD8+ T cells is the consequence of the 
diversity of the remaining T cells, particularly those that share the same TCR 
Vb element (Messaoudi et al., 2004). This could have a profound impact on 
TCR diversity. Analysis of the TCRVb chain presented a decreased antigen-
recognition repertoire from approximately 108 in young adults to 106 in older 
individuals (Weng 2006;) with a drastic contraction in CD4+ T-cell diversity in 
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the seventh and eighth decades of life (Naylor et al., 2005). Studies in mice 
have determined that a twofold to tenfold decrease in diversity is sufficient to 
jeopardize a T-cell-mediated immune response, thereby leaving the elderly 
more susceptible to new pathogens. Examination of lymphocyte lifespan has 
shown variations in subsets, but all are finite. Human CD4+ T cells have 
around 33 population doublings in culture (Pawelec et al., 1996) whereas CD8+ 
T cells have only around 23 (Perillo NL, et al., 1993).  The restraint dictating 
lifespan is believed to be telomere-dependent and analysis of telomere length 
displays significantly shorter telomeres in old individuals among all T-cell 
subsets (Akbar et al., 2004). These cells, which have undergone replicative 
senescence, accumulate with age and many, particularly in the CD8+ memory 
subset, are specific to only certain persistent infections (Akbar et al., 2005). 
Therefore immunosenescence is characterized by a progressive reduction of 
peripheral naïve T cells (Fagnoni et al., 2000), by an increase of memory T cells 
(Cossarizza et al., 1996) and of CD28- T lymphocytes (Fagnoni et al., 1996) 
accompanied by a clonal expansions of CD8+ T lymphocytes specific for viral 
epitope (CMV, EBV) producing inflammatory cytokines (Vescovini et al., 2004) 
and filling the "immunological space" (Franceschi et al., 2000a) leading to a 
progressive development of a chronic inflammatory status, known as 
"inflammaging", (Franceschi et al., 2000b) 2005; Ginaldi et al., 2005; De 
Martinis et al., 2006; Rudin and Barzilai, 2005)  
1.3.2.4 Phenotype of peripheral T cells 
The T cell population can be divided into distinct subsets based on their 
phenotype, i.e. the expression of diverse cell surface receptors. The most-
commonly used markers are CD45RA (or CD45RO), CCR7, CD27, CD28 and 
CD95. Beyond the precise identification of naïve T cells (CD45RA+CCR7+ 
CD27+CD28+), the differential expression of these four molecules allows the 
distinction between numerous subsets of ‗‗resting‘‘ (referring to cells that are 
not involved in primary or acute infection phases) antigen-experienced T 
cells. However, it is essential to notice that the expression of a surprisingly 
large number of markers significantly overlap or associate with each other, 
as summarized in Figure III. The expression of markers, commonly used to 
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define CD8 T cell subsets, enables also the distinction between several CD4 
T cell subpopulations, including CD4 cytotoxic T cells. Functionally distinct 
CD4 T cell populations can also be subdivided according to the expression of 
chemokine receptors (Figure IV A and IV B) 
 
Figure III Phenotype and function of CD8+ T cells 
 
Figure III. Phenotypic associations within CD8 T cell subsets in humans and relationship with functional 
attributes. Five distinct subsets of circulating CD8 T cells are defined according to the expression of CD27, CD28, 
CCR7, and CD45RA. Relative telomere length and expression of a variety of cell surface receptors and 
intracellular molecules (related to T cell activation, costimulation, regulation, homeostasis, homing potential, and 
functional capacities) are illustrated in these subsets in a ‗‗resting‘‘ state according to data from the literature. The 
common phenotypic distribution of virus specific CD8 T cells is also depicted, after clearance of the virus (Flu) or 
in latent infection stages (for HCV, EBV, HIV, and CMV)From Appay et al. 2008.  
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It is important to note that these observations and relationships between T 
cell phenotype and functional attributes, as well as between T cell profile 
and pathogen have been established in the context of resting cells, that is to 
say, for cells that are not actively stimulated (e.g., by cognate antigen). 
Many of these observations do not hold in a setting of T cell activation or 
inflammation. In fact, inflammatory settings, the T cell environment is also 
altered, which can result in further changes of T cell behavior. 
 
Figure IV Phenotype and function of CD4+ T cell 
 
Figure IV. Phenotypic dissection of human CD4 T cells into functionally distinct subsets. (A) The expression of 
chemokine receptors is associated with CD4 T cell subpopulations presenting distinct TH cytokine profiles. (B) The 
expression of markers, commonly used to define CD8 T cell subsets, enables also the distinction between several 
CD4 T cell subpopulations, including CD4 cytotoxic T cells. From Appay et al. 2008. 
 
For instance, T lymphocytes lacking the lymph node-homing receptors L-
selectin and CCR7 do not migrate to lymph nodes in the steady state 
(Sallusto et al., 1999). Nonetheless, studies in the mouse have revealed that 
inflammatory or reactive lymph nodes (i.e., draining sites of mature 
dendritic cells) can recruit L-selectin-negative CCR7-T cells. 
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It is of utmost importance to note that there is no harmonization of 
nomenclature. Even basic terms like ‗‗memory,‘‘ ‗‗activated,‘‘ and ‗‗effector‘‘ 
have different meaning in the literature. Memory T cells may be defined as 
cells that have seen or been primed with an antigen (persistent or not). 
Activated T cells are sometimes referred to as cells that are simply no longer 
naïve (having been activated at some point by antigens), and are also 
referred as cells that have been very recently stimulated with an antigen 
(and, for example, may be entering mitosis). Effector T cells can be present 
during the primary or secondary phases of an infection, when fighting to 
halt active viral replication, or they can simply be cells which display 
effector functions ex vivo (like IFN- secretion or perforin content). In 
humans, longitudinal studies of T cell responses (e.g., from primary 
infection onwards) they  are rare (for practical reasons) so that distinct 
subsets of resting cells are usually compared with each other at a given time 
point. It is also important to consider that infections with different 
pathogens represent different settings, for which comparing respective 
immune responses may not always be as straightforward as it seems. What 
is observed in one system is not necessarily valid in another system and 
different requirements in terms of T cell efficacy may potentially be 
involved. Last but not least, observations made in the human system do not 
necessarily apply to the mouse system, and vice versa. It is clear that undue 
extrapolation and generalization of findings across models and conditions is 
a problem, which can be a major source of confusion. Full understanding of 
T cell immunity will require making every effort to perform longitudinal 
studies in humans and to take in consideration changes of T cell attributes 
upon activation and pathogen-specific settings. 
1.3.3. Cytomegalovirus (CMV) and immune aging 
Cytomegalovirus (CMV) is one of the eight human herpes viruses and its 
seroprevalence ranges from 60 to >95% in different populations. In western 
countries infection rates increase gradually with age, such that 
approximately 70% of individuals over the age of 60 years are CMV-
seropositive. 
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Epidemiological studies of elderly Scandinavian individuals associated 
CMV-seropositivity with the development of an ―immune risk phenotype‖ 
which was predictive of early mortality (Strindhall J et al., 2007).  
Functional studies suggest that the major structural protein pp65 and, to a 
lesser extent,  the immediate early protein 1, IE-1 constitute major antigens 
against which aged people target functionally efficient T cell effector 
responses with massive production of Th1 cytokines and exhibition of 
CD107a degranulation marker. As a result, the production of IFN-gamma 
induced in T cells by both antigens was seven to eight times greater in very 
old than in young subjects. The comparative analysis of pp65-specific 
responses in these very long-term carriers revealed a reciprocal relationship 
between CD4+ and CD8+ producing IFN-gamma in the same individuals. 
Such a remarkable burden of effector CD4+ and CD8+ T cells may be 
necessary to protect the elderly from CMV endogenous reactivation, but can 
turn detrimental by giving a substantial contribution to the 
proinflammatory status that accompanies the main age-related diseases. 
Antibody responses to HCMV, but not to EBV, and anti-HCMV CD4+, but 
not CD8+, T cell responses were more intense in elderly subjects aged 85 
years over in poor health and were inversely correlated with markers of 
functional activity and cognitive function. Therefore, humoral and CD4+ T 
cell anti-HCMV responses were specifically intensified in advanced aging 
associated with comorbidity and cognitive and functional impairments. Such 
a distinctive pattern of adaptive immunity indicates that immune responses 
targeting the extracellular phase of HCMV are increased in these elderly 
subjects and could represent an indirect effect of localized and undetectable 
HCMV reactivation. These studies demonstrate that the oldest subjects in 
poor health with physical and cognitive impairment express intense 
functional immune responses to extracellular HCMV and suggest that they 
may be at risk for direct pathogenic effects by HCMV reactivation as well as 
indirect pathogenic effects linked to proinflammatory anti-HCMV effector 
responses. These results indicate that CMV represents an important 
pathogen responsible for a strong immune activation in human aging 
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(Vescovini et al., 2007; Vescovini et al., 2010). Moreover a recent paper 
indicated that mouse CMV, MCMV, significantly increased expression of 
pro-inflammatory cytokines such as IL-6, TNF-, and MCP-1 and that CMV 
stimulated expression of renin in mouse and human cells in an infectious 
dose-dependent manner.  
Consistent with the findings of the mouse trial, human CMV (HCMV) 
infection of blood vessel endothelial cells (EC) induced renin expression in a 
non-lytic infection manner. These results show that CMV infection is a risk 
factor for increased arterial blood pressure, and is a co-factor in aortic 
atherosclerosis. Control of CMV infection can be developed to restrict 
hypertension and atherosclerosis in the cardiovascular system (Cheng J et 
al., 2009). 
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2. Materials and Methods 
 
2.1.   The recruitment procedure 
 
2.1.1.  Preliminary and preparatory activities to the recruitment 
Set up and standardization of the Informed Consent Forms, taking into 
account the Italian legislation in order to obtain the approval of the local 
ethical committees.  
Set up of a common introductory letter to be presented to the people asked 
to participate in the study, in connection with a common informed consent 
form in order to give the participants a qualified basis for decision on 
participation. This introductory letter, written in a clear and 
understandable way for the recipients, explained the purpose and 
background of the study and that participating to the study would include a 
visit of approximately 90 minutes by a research nurse or interviewer and a 
blood sample to be taken. It also underlined that participation did not 
involve any risk for the participants, that participation was completely 
voluntary, and that the participant could resign from the study at any time. 
Set up and standardization of a Questionnaire containing socio-demographic 
information (education); clinical and anamnestic data; functional activity 
(ADL and IADL); life style habits; physical performance (handgrip-function, 
chair stand); cognitive function (SMMSE); self-reported health. Then, the 
interviewer team contacted the subjects and explained them the type of 
research envisaged by the project, its aim and scope, and the role of the 
subjects in it. Particular attention was paid to illustrate the storage and use 
of the biological material derived from their blood donation (plasma, cells, 
etc). After obtaining the informed consent, the interviewer (a MD, 
preferably a geriatrician, or a specifically trained biologist, biotechnologist) 
administered the questionnaire, collected the clinical history using the 
standardized case sheet, performed a clinical and functional examination, 
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collected blood sample and stored the biological material (plasma, serum, 
DNA and blood cells). 
Each sample was identified with an identification code named as PID for 
personal information. The PID is designed to be used during all phases of 
recruitment and for the material used by the recruiting teams. 
Questionnaires, tubes and work sheets are labelled with the PID. The PID 
is composed by 8 number specifying for: 
1. The name of the recruiting unit (1 digit); 
2. To which group subject belonging (3 digit), if they were centenarian 
offspring or subjects with both parents non long-lived; 
3. Progressive number (3 digit) from 001 to 100 for centenarians 
offspring whose centenarian parent participate to the study and from 
900-999 for subjects whose centenarian parents refused to 
participate to the study and  from offspring of non long lived parents; 
4. To discriminate how much siblings participate to the study (1 if only 
one subject participate and 2 and 3 if more siblings participate); 
offspring of non long-lived parents have 0. 
2.1.2. Sample collection, processing, storing and shipment 
A) Whole Blood 
For each patient 3 tubes of EDTA (3ml and 9 ml), 2 tubes of NaCitr (3 ml 
each), 2 tubes  of Clot Activator (3 ml each) whole blood were collected.  
The first tube of EDTA blood (3 ml) was used to perform the principal 
emato-chemical analysis (total number of leukocytes, red blood cells, 
hemoglobin, platelets and leukocyte differential count; blood concentration 
of glucose, blood concentration of insulin, cholesterol, HDL, LDL, bilirubin, 
albumin, triglycerides, transaminases, etc);  
One ml of the second EDTA tube (3 ml) was put into a 96 deep-well and 
stored at -20°C for DNA extraction. The rest was store at -20°C as backup 
aliquots. 
Approximately 1 ml of whole blood from the third tube (9 ml) was used to 
perform immune phenotype analysis of the principal lymphocyte 
subpopulations. 
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The third tube of EDTA blood (9 ml) together with 2 tubes of NaCit blood 
was centrifuged (1000g) to obtain plasma aliquots that were stored at -80°C. 
About ten aliquots of plasma EDTA were stored at -80°C until the time of 
the analysis and then used to determine cytokines and adipokines  
concentration. A part of NaCitr plasma aliquots was delivered to the 
University of Milan while the rest was stored  at -80°C in local laboratory as 
backup. 
Two tubes of Clot Activator whole blood were centrifuge at 769g for 20 
minutes to obtain serum samples and then were stored at -80°C until the 
time of analysis. Insulin determination and CMV-serology were performed 
on serum samples. 
B) Other biological samples 
For each patient urine was collected. 4 aliquots of urine (1.5 ml each) were 
stored at –80°C. 
Moreover, of a part of these subjects, faeces were collected and stored at –
80°C. 
 
2.1.3. Which threshold for longevity? 
Subjects eligible to participate to the study were recruited following strict 
demographic criteria. Centenarians offspring and controls, that are 
individuals in their seventies, had to have both parents born in the same 
birth cohort, that is 1900-1908 and dead by non accidental cause. 
But which age threshold would be chosen to classify parents in long-lived or 
not long-lived individuals? 
They were classified in long-lived or non long-lived on the basis of the 
average life expectancy at 15 years for the birth cohort considered that is, 
for birth cohort 1900-1908, 67 years old for male and 72 years old for female. 
By asking directly to subjects to remember the date of birth and death of 
their parents and the cause of death it has been possible classify these 
individuals in long-lived and non long-lived, according to the average life 
expectancy.  
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Once obtained this classification subjects were divided in the following 
groups:  
-Centenarians Offspring (having both parents born between 1900-1908 with 
at least one centenarian); 
-Offspring of both non long-lived parents, (having both parents born 
between 1900-1908 and dead at an age lower than the mean life expectancy) 
 
2.1.4. Population of the Study 
A total of  374 subjects were recruited in Northern Italy by the University of 
Milan, Parma, Bologna and Florence (Milan, Parma, Bologna, and Florence 
district). These subjects were divided into 2 groups:  
 centenarians offspring (109 males and 158 females, mean age = 70.2 
years)  
 offspring of non long-lived parents (56 males and  51 females, mean 
age = 71.1)  
The local Ethical Committees, Comitato Etico Indipendente Policlinico 
S.Orsola Malpighi (UNIBO) approved the study protocol.   
Population registration took place at the municipal level through ―Anagrafe‖ 
system. A letter was sent to all municipalities asking for list of long-lived 
persons and for controls and their family. More time was spent by MD, 
biologists and biotechnologists at the Anagraphe of Bologna to search 
through the paper register and import in electronic format a list of subjects 
complied with the design of the study. This phase lasted more than two 
years. 
Eligible subjects were then contacted by an informative letter. After a week 
subjects were contacted by phone to obtain the consent and to fix an 
appointment for the home interview and blood withdrawal. 
Subjects affected by malignant neoplasia and/or in therapy with 
immunosuppressor drugs (like cyclosporine, methotrexate, glucocorticoid, 
etc.) or anti-coagulant drugs were excluded from the study. 
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2.2. Variables assessed by the questionnaire and included in the analysis 
2.2.1. Sociodemographic Factors 
Questions about education and marital status. Education was reported both 
as mean of years and as prevalence of subjects obtained higher level of 
education. Higher education indicate subjects who successfully completed at 
least thirteen years of education. 
2.2.2. Lifestyle Factors 
Questions about smoking habits and alcohol consumption. Smoking was 
indicated as current and former smokers.  
2.2.3. Disability assessment  
The functional disability was assessed by the Katz Index of activities of 
daily living (ADL) and by the Lawton Instrumental Activities of Daily 
Living (IADL) scale.  
The Katz Index of ADL including bathing, toileting, transfer, feeding  and 
continence was used to classify subjects in ―not disabled― as independent in 
all items, ―moderately disabled‖ as dependent in one or two items, and 
―severely disabled‖ as dependent in three or more items in accordance with 
the definitions given in Katz‘paper (Katz S., 1970). These categories define 
three sizable groups which ranged from a group capable of doing the most 
basic activities independently to a group that was dependent in the majority 
of the six basic activities. The mean value of the score was reported in the 
analysis. 
The Lawton (Lawton, M.P., 1969) IADL scale assesses a person‘s ability to 
perform tasks and may provide an early warning of functional decline or 
signal the need for further assessment. It measures eight domains such as 
preparing food, housekeeping, doing laundry, handling medications, getting 
to places beyond walking distance, going shopping,  handling finances and 
using a telephone. The Lawton IADL scale scores from 0 (low function) to 8 
(high function). 
Competence in skills such as shopping, cooking, and managing finances is 
required for independent living. Because IADL function  is usually lost 
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before ADL function (such as bathing, eating, and using the toilet), 
assessment of IADLs may identify incipient decline—physical, cognitive, or 
both—in an older adult who might otherwise appear capable and healthy. 
The mean value of the score was reported in the analysis. 
The disability was also assessed by the Nagi scheme, developed in the 1960s 
by sociologist Saad Nagi. To patients it was asked whether they were able to 
perform some activities with or without help (Nagi S. and 1965).  
Handgrip strength and ability to perform a five times chair stand test were 
included in the study. Handgrip strength was measured using a hand-held 
dynamometer (SMEDLYS‘ dynamometer, Scandidact, Kvistgaard, 
Denmark) for two performances with each hand. The best performance of 
these four was used for the analysis (Nybo H et al., 2001; Jeune B et al., 
2006). 
The ‗repeated chair stand‘ is a screening test to assess the overall 
performance of the lower limbs (Wolinsky et al., 2005). The use of arms or 
aids such as canes was not permitted. In the chair stand test, participants 
were divided in two groups (able to complete the test and unable to complete 
the test). 
2.2.4. Cognitive function 
Cognitive function was measured using the mini-mental state examination 
(MMSE) (Folstein MF, 1975). This test is a brief 30-point questionnaire that 
is used to screen for cognitive impairment. It is commonly used in medicine 
to screen for dementia. Cognitive impairment was graded as severe (0-17 
points), mild (18-23 points), and not present (24-30 points). The score used 
in the analysis was corrected by age and years of educations according to 
Magni for old people (Magni et al., 1996). The mean value of the score was 
reported in the analysis. 
Age-range 65-69 70-74 75-79 80-84 85-89 
Years of 
education 
     
0-4 years +0,4 +0,7 +1,0 +1,5 +2,2 
5-7 years -1,1 -0,7 -0,3 +0,4 +1,4 
8-12 years -2,0 -1,6 -1,0 -0,3 +0,8 
13-17 years -2,8 -2,3 -1,7 -0,9 +0,3 
 
 
29 
 
Presence of depression was evaluated through Geriatric Depression Scale, 
GDS and graded as absent (0-5 score) or present (>5 points), (Yesavage et al. 
1982; Sheikh JI, et al., 1986). The mean value of the score was reported in the 
analysis. 
2.2.5. Perceived health 
Perceived health status was assessed by EQ-5D and EQ VAS to obtain 
health profile. The EQ-5D descriptive system comprises five dimensions: 
mobility, self-care, usual activities, pain/discomfort and anxiety/depression. 
Each dimension has three levels: no problems, some problems, extreme 
problems. The subjects were asked to indicate their health state. In the 
analysis the EQ-5D levels were dichotomized into ―no problems‖ and 
―problems‖. EQ-VAS records the subjects self-rated health on a vertical, 
visual analogue scale where the endpoints are labeled ―best imaginable 
health state‖ and ―worst imaginable health state‖. This information can be 
used as a quantitative measure of health outcome as judged by the 
individual respondents. Moreover perceived health status was assessed by 
asking participants how they considered their health status with 5 possible 
answers: very good, good, fair, poor and very poor. In the analysis these 
responses were clustered in very good/good, fair, poor/very poor. Finally it 
was asked to participants which was their attitude towards life with three 
possible answers: optimistic, pessimistic and neither one nor other. 
2.2.6. Prevalence of diseases 
Participants were questioned about a list of 31 possible diseases, 7 of which 
occurred in the past and the remaining still affecting the patients. Each 
participant was classified according to the presence of  0, 1-2 or 3 or more 
diseases to obtain a multimorbidity index.  
2.2.7.Anthropometric features 
Body mass index (hg/m2) was calculated using measured height and weight. 
Mean value and the number of subjects having a BMI over 25, indicating 
overweight were used in the analysis. The height data used for the analysis 
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were measured by the interviewers using a common metre. The weight data 
were measured using a common scale (SECA Mod. 761). 
2.3. Immunophenotype characterization 
The immunophenotype characterization was performed using fluorochrome-
conjugated monoclonal antibodies (mAbs) direct against the following 
lymphocyte surface markers: 
CD3 a T-Cell Co-Receptor protein complex composed of four distinct 
chains involved in T lymphocytes activation; 
CD4  a glycoprotein expressed on the surface of T helper cells; 
CD8  a transmembrane glycoprotein and it is predominantly 
expressed on the surface of cytotoxic T cells; 
CD5  a cluster of differentiation found on a subset of IgM-secreting B 
cells called B-1 cells, and also on T cells; 
CD19  a protein expressed on follicular dendritic cells and B cells; 
CD16  the Fc receptors FcγRIIIa and FcγRIIIb. It is found on the 
surface of natural killer cells, neutrophil polymorphonuclear 
leukocytes, monocytes and macrophages; 
CD56  also called Neural Cell Adhesion Molecule, NCAM, is a 
homophilic binding glycoprotein expressed on the surface of 
neurons, glia, skeletal muscle and natural killer cells; 
CD28  one of the molecules expressed on T cells that provide co-
stimulatory signals, which are required for T cell activation. 
CD28 is the receptor for B7.1 (CD80) and B7.2 (CD86); 
CD95  also known as Fas receptor, FasR, is a death receptor on the 
surface of cells that leads to programmed cell death (apoptosis). 
CD45RA CD45RA is an isoform of CD45 antigen which was originally 
called leukocyte common antigen. CD45RA is located on naive 
T cells;  
CCR7   or CD197 is a C-C chemokine receptor type 7. It controls the 
migration property of  T cells to lymph node and inflamed 
tissues, as well as stimulate dendritic cell maturation. 
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The identification of the major lymphocyte subsets (NK cells, B and T 
lymphocytes, helper and cytotoxic T lymphocytes, virgin/naïve, memory and 
effector T lymphocytes), some of them considered important for the 
immunological risk phenotype (IRP) (Strindhall J, et al., 2007) or 
immunological markers predictors of mortality, were performed by flow 
cytometry analysis on fresh blood sample using the following combination of 
mAbs: CD16/CD56/CD3 to identify NK cells  (CD16+CD56+CD3-), CD5/CD19 
to identify B (CD5-CD19+), CD4/CD8/CD3 to identify cytotoxic (CD4-
CD8+CD3+) and helper (CD4+CD8-CD3+)  T lymphocytes, CD28/CD95/CD4-
CD8 to identify virgin (CD28+CD95-), memory/activated (CD28+CD95+) and 
effector (CD28-CD95+) T lymphocytes, CD45RA/CCR7/CD4-CD8 to identify 
virgin (CD45RA+CCR7+), central memory (CD45RA-CCR7+), effector 
memory (CD45RA-CCR7-), and terminally differentiated (CD45RA+CCR7-) T 
lymphocytes.  
2.3.1 Method 
Surface staining was performed on whole blood with EDTA as anticoagulant 
agent, using the following mAbs: FITC, PE or PE-Cy7-conjugated mAbs 
directed against CD3, CD4, CD8, CD95, CD28, CD16, CD56, CD45RA, 
CCR7 and isotype-matched irrelevant Abs (all from BD Biosciences, San 
Jose, CA). One hundred microliters of blood were incubated with saturating 
amounts of the mAbs for 20 minutes at room temperature and then were 
lysed with FACS Lysing Solution (BD Biosciences). Three-parameter flow 
cytometric acquisition was performed on a FACSCalibur instrument (BD 
Biosciences) using CellQuest software (BD Biosciences). A minimum of 
30,000 cells for each tube were acquired. The data collected by flow 
cytometry were then exported and analyzed with Flowjo Software. The 
percentage of B, T and NK cells was calculated on lymphocyte gate in 
accordance to Forward (FSC) and Side (SSC) scatter. The percentage of 
helper and cytotoxic T lymphocytes was calculated inside the CD3 gate 
making an electronic gate on cells positive to this marker. The analysis of 
the combined expression of CD95 and CD28 as well as CD45RA and CCR7 
was done inside the CD4 and CD8 gate.  
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2.4. CMV serology 
Indirect chemiluminescence immunoassay (Liaison CMV IgG assay; 
DiaSorin) was used for the quantitative determination of serum-specific IgG 
antibodies, Abs, to human CMV. Samples were analyzed by a 
photomultiplier Liaison. All donors recruited were classified CMV positive if 
they had the IgG levels higher 0.6 IU/mL and CMV negative otherwise. 
 
2.5. Evaluation of plasma cytokines and IGF-1 levels 
Concentration of pro- and anti-inflammatory cytokines and adipokines (IL-
6, TNF-, IL-10, leptin, resistin, adiponectin and serum amyloid A) in 
plasma samples of enrolled subjects were measured by multiplex sandwich 
ELISA technology (SearchLight, Aushon Biosystems, Billerica, MA) 
according to the manufacturer‘s instructions. The concentration of each 
analyte in the array was detected by biotin-streptavidin reaction and 
quantified by a SearchLight CCD Imaging System. In particular, 3 
multiplex kits were utilized: a custom 3-Plex Array able to measure at same 
time IL-6, IL-10 and TNF- a custom 2-Plex Array able to detect 
simultaneously leptin and resistin and a custom 2-Plex Array able to detect 
at the same time adiponectin and serum amyloid A. Samples, standards, 
and reagents were dispensed in the plates by a standardized technique 
employing a robotic liquid handling system with 16 channels (Microlab
® 
STAR, Hamilton Robotics, Reno, NV).  
Plasmatic TGF-1 concentration was determined by ELISA using a 
commercial kit (DRG Instruments GmbH, Marburg, Germany) according to 
the manufacturer‘s instructions. The analytical sensitivity was 1.2 pg/ml. 
The interassay coefficient of variation was 7.5%. Concentration of TGF-1 
was detected and quantified by a SynergyTM HT Multi-Detection 
Microplate Reader (Bio-Tek® Instruments, Winooski, VT). The serum level 
of IGF-1 was measured using an enzymatic immunoassay kit (mediagnost®, 
Germany) following the manufacture‘s instruction. Total IGF-I was assayed 
by one-step sandwich chemiluminescence immunoassay (CLIA) after prior 
separation of IGF-I from binding proteins on the Liaison autoanalyzer 
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(DiaSorin, Saluggia, Italy). Intraassay and interassay CV were 4.4 and 
5.5%, respectively. 
 
2.6. Statistical Analysis 
Preliminary examination of the difference between centenarians offspring and 
controls were performed using chi square analyses for qualitative variables 
and t test or Mann-Whitney non parametric U test for quantitative variables. 
When appropriate variables were log transformed. 
Logistic regression was used to examine the relationship between 
qualitative and quantitative variables and offspring status. Age, gender, 
smoking, education, marital status, BMI and waist circumference were 
entered in the regression model as covariates.  
Subjects suffering for malignancies and those that have taken anti-
inflammatory medication in the week before the blood withdrawal were 
excluded from the cytokines and immunophenotype analysis. The statistical 
analysis was performed using SPSS 15.0 for windows. 
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3. Aim of the Study 
Data on centenarians, centenarians siblings and offspring of long lived 
parents are compatible with the hypothesis that longevity and successful 
aging have a strong familiar component.  An increasing amount of data 
indicates that centenarians offspring undergoes a better aging process than 
that of subjects of the same age born from non long-lived parents. In 
particular it seems that these individuals had a lower prevalence of the 
major age-related pathologies such as cardiovascular diseases (CVD), 
diabetes and hypertension but data regarding functional, cognitive and 
physical abilities, i.e. MMSE, hand grip, chair stand, and others, are very 
scant or absent. 
In humans, it is becoming recognized that the immune system declines with 
age, a process named immunosenescence, leading to a higher incidence of 
infections, neoplasia and autoimmune diseases and contributing to 
determine the overall health status. Immunosenescence is characterized by 
a progressive reduction of peripheral virgin T cells, by an increase of 
memory T cells and of CD28- T lymphocytes accompanied by a progressive 
increase of CD8+ T lymphocytes specific for viral epitope (CMV, EBV) and by 
a progressive development of a low-grade chronic inflammatory status, 
known as "inflammaging". Data concerning the immunological aspects i.e. 
lymphocyte subpopulation and pro and anti-inflammatory cytokines are not 
present in literature in centenarians' offspring model. 
However at present it is still unknown how much longevity and successful 
aging is due to genetics. This is a crucial issue from a theoretical (biology) 
and practical (biomedicine and public health) point of view, and this 
research project is aimed to contribute to its clarification. 
In conclusion, the aim of the study was to determine if subjects with at least 
a centenarian parent could experience a better health status compared to 
offspring of non long-lived parents considering not only socio-demographic, 
life-style and functional aspects but also inflammatory, metabolic and 
immunological parameters known to impact on the aging process.  
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For this purpose a group of centenarians offspring and offspring of non long-
lived parents have been recruited and characterized by a great number of 
parameters able to determine their healthy status.  
Centenarian‘s offspring have been chosen because they represent one of the 
best models to study the different components contributing to human aging 
and longevity without the disadvantages inherent in the study of 
centenarians such as rarity, lack of a control group of the same age, 
presence of frailty due to extreme age. In fact, centenarian's offspring are on 
average seventy years old, are more numerous than centenarians and it is 
possible to compare them with a demographically-matched control group 
(subjects matched for age, sex, ethnicity, parent year of birth, but born from 
non long-lived parents) thus avoiding cohort effects. 
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4. Results  
 
4.1.    Study Population 
A total of 267 centenarians offspring (109 male, mean age 70.2 ± 6.3 and 158 
female, mean age 70.2 ± 6.8) and 107 offspring of non long-lived parents (56 
male, mean age 70.2 ± 6.3 and 51 female, mean age 72.0 ± 5.6) were 
recruited. After obtaining the informed consent, a standardized 
questionnaire was administered to each participant. The strategy of 
enrolment and management of the data are described in details in Material 
and Methods. Moreover a blood sample was collected for hematochemical 
analysis and immunophenotype staining. All the data were entered in a 
database to perform statistical analyses. The main characteristics of the 
study population were reported in Table I. Age was not different between 
the two groups while the proportion of females is higher in the group of 
centenarians offspring compared to controls (p=.04). Hereafter the terms 
offspring of non long-lived parents and controls will be used 
interchangeably. 
 
Table I. Study Population 
Study Population 
Centenarians 
offspring, 
n=267 
Offspring of non 
long-lived parents, 
n=107 
p-value 
Age, mean (SD), y 70.2 (6.6) 71.1 (6.0) ns 
Male, n (%) 109 (40.8) 56 (52.3) 
.04 
Female, n (%) 158 (59.2) 51 (47.7) 
 
 
Table I. Study Population. SD=standard deviation; y=years. 
 
4.2. Demographic, lifestyle characteristics and functional status of 
participants 
A large number of studies showed that the aging process differently affects 
males and females. In light of this evidence a first analysis was conducted 
separately for both sexes. Results concerning socio-demographic, life-style  
and functional aspects are reported in Table II and Table III.  
Considering socio-demographic and life-style characteristics no significant 
difference was found between male centenarians offspring and male 
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offspring of non long-lived parents, while female centenarians offspring had 
a significant higher level of education and a different distribution within 
marital status compared to female controls (Table II).  
Regarding the anthropometric variables no difference was found between 
male centenarians offspring and male controls whereas female centenarians 
offspring showed a significantly lower weight, waist and hip circumferences 
than female controls. Furthermore, the mean value of body mass index, 
BMI, as well as the proportion of subjects with a BMI over 25 were lower in 
female centenarians offspring compared to female controls. 
In addition, since the simultaneous presence of more pathologies or ailments 
is a common feature of the aged people a multimorbidity index based on the 
pathologies or conditions that affected the subjects was created. Each 
enrolled individual was classified into three levels: (0, 1-2 and >2 illnesses).  
A lower prevalence of female centenarians offspring with more than two 
pathologies was found compared with female controls and a similar trend 
was observed for men although it was not significant (Table II). No 
difference was found between the two groups both in males and in females 
in the other parameters shown in Table II.   
In Table III cognitive status and physical performances of participants were 
indicated. Even in this case no difference was found between male 
centenarians offspring and controls while female centenarians offspring had 
obtained a better performance in the hand grip test and also a significantly 
higher proportion of these subjects was capable of performing a chair stand 
test, walking 500 meters and climbing up and down the stairs without aid 
than female controls. 
In order to determine which variables were associated with the 
centenarians offspring condition a logistic regression analysis, adjusted  for 
age and gender, was performed in the studied population. 
In Table IV the baseline characteristics of the study population were 
reported. Life-style habits and education were not different between 
centenarians offspring and controls.  
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Furthermore a statistically significant different distribution of subjects 
between groups was observed concerning the marital status, with a higher 
percentage of singles and divorced in the centenarians offspring group than 
in controls. 
 
Table II. Baseline Characteristics of Participant 
Sociodemographic and  
life-style characteristics  
Centenarians 
offspring 
Offspring of non 
long-lived parents 
p-value 
OR 
(95% CI)  
Male, n 109  56   
Age, mean (SD) 70.2 (6.3) 70.2 (6.3) .06  
Life-stlyle     
Current smokers, n (%) 13 (12.3) 9 (16.4) ns  
Former smokers, n (%) 56 (58.9) 27 (60.0) ns  
Alcohol consumption, n (%)     
Education     
Years, mean (SD) 11.3 (5.2) 10.8 (4.8) ns  
Higher education, n (%) 55 (51.4) 27 (50.0) ns 0.98 (0.79-1.22) 
Marital status     
Never married, n (%) 12 (11.1) 0 (0.0)   
Married, n (%) 84 (77.8) 48 (87.3) .06  
Divorced, n (%) 6 (5.6) 2 (3.6)   
Widow/widower, n (%) 6 (5.6) 5 (9.1)   
Anthropometric features     
Weight, kg, mean (SD) 77.0 (12.3) 79.1 (12.4) ns  
Height, m, mean (SD) 1.7 (7.0) 1.7 (6.8) ns  
BMI, kg/m2, mean (SD)  26.9 (3.4) 27.8 (3.9) ns  
BMI>25, n (%) 73 (68.9) 41 (74.5) ns 1.10 (0.88-1.38) 
Waist circumference,  
mean (SD) 
97.4 (10.8) 97.8 (10.1) ns  
Hip circumference,  
mean (SD) 
103.7 (9.0) 101.8 (14.9) ns  
Multimorbidity Index     
0 diseases, n (%) 19 (17.9) 8 (14.5)   
1-2, n (%) 60 (56.6) 24 (43.6) ns  
>2, n (%) 27 (25.5) 23 (41.8)   
Female, n 158 51   
Age, mean (SD) 70.2 (6.8) 72.0 (5.6) ns  
Life-stlyle     
Current smokers, n (%) 25 (15.9) 9 (17.6) ns  
Former smokers, n (%) 46 (35.4) 12 (28.6) ns  
Alcohol consumption, n (%)     
Education     
Years, mean (SD) 11.0 (4.9) 9.3 (3.7) .01  
Higher education, n (%) 75 (47.5) 13 (26.5) .01 0.82 (0.71-0.95) 
Marital status     
Never married, n (%) 31 (19.6) 2 (4.0)   
Married, n (%) 74 (46.8) 33 (66.0) .02  
Divorced, n (%) 8 (5.1) 1 (2.0)   
Widow/widower, n (%) 45 (28.5) 14 (28.0)   
Anthropometric features     
Weight, kg, mean (SD) 64.6 (11.4) 70.7 (12.0) .002  
Height, m, mean (SD) 1.6 (6.8) 1.6 (6.6) ns  
BMI, kg/m2, mean (SD)  26.3 (5.0) 28.3 (4.4) .01  
BMI>25, n (%) 85 (55.2) 38 (77.6) .005 1.25 (1.08-1.45) 
Waist circumference,  
mean (SD) 
86.5 (12.6) 92.4 (12.1) .004  
Hip circumference,  
mean (SD) 
103.3 (10.8) 107.8 (9.2) .01 
 
Multimorbidity Index     
0 diseases, n (%) 16 (10.5) 0 (0.0)   
1-2, n (%) 58 (37.9) 13 (27.7) .01  
>2, n (%) 79 (51.6) 34 (72.3)   
 
 
Table II. Baseline Characteristics of Participants. SD=standard deviation; OR=odds ratio; BMI=Body Mass Index. 
 
 
Regarding the anthropometric features it was observed that centenarians 
offspring were leaner than controls considering weight and waist 
39 
 
circumference. Moreover it was found that centenarians offspring had a 
significantly lower BMI and a lower proportion of individuals with a BMI 
over 25 in comparison to controls, suggesting that not only gender but also 
genetic, environmental and life-style factors could explain these differences. 
 
Table III. Health and functional status of Participants 
Health and function  
Centenarians 
offspring 
Offspring of non 
long-lived parents 
p-value 
OR 
(95% CI)  
Male, n 109  56   
ADL score, mean (SEM) 5.9 (0.3) 5.9 (0.5) ns  
IADL score, mean (SEM) 7.9 (0.4) 7.7 (0.9) ns  
MMSE score, mean (SEM) 27.6 (1.2) 27.3 (1.5) ns  
Handgrip strength, Kg, mean (SD) 38.1 (7.3) 37.0 (7.4) ns  
Ability to perform chair stand, n (%) 103 (97.2) 46 (88.5) .06 2.07 (0.82-5.26) 
Walk about half a kilometer w/o 
walking aid, n (%) 
107 (99.1) 53 (96.4) ns 2.01 (0.40-9.98) 
Go up and down the stairs w/o 
anyone‘s help, n (%) 
101 (93.5) 47 (85.5) ns 1.68 (0.99-2.85) 
Do the patient use any aid? n (%) 2 (1.9) 4 (7.3) ns 2.02 (0.65-6.29) 
Female, n 158 51   
ADL score, mean (SEM) 5.8 (0.6) 5.5 (1.0) .07  
IADL score, mean (SEM) 7.9 (0.6) 7.7 (1.3) ns  
MMSE score, mean (SEM) 27.6 (1.5) 26.9 (3.2) ns  
Handgrip strength, Kg, mean (SD) 23.9 (5.5) 21.2 (5.0) .002  
Ability to perform chair stand, n (%) 146 (95.4) 40 (80.0) .001 1.91 (1.07-3.38) 
Walk about half a kilometer w/o 
walking aid, n (%) 
145 (92.9) 41 (82.0) .02 1.42 (0.95-2.12) 
Go up and down the stairs w/o 
anyone‘s help, n (%) 
125 (79.6) 28 (56.0) .001 2.26 (1.40-6.06) 
Do the patient use any aid? n (%) 7 (4.5) 6 (12.0) .06 1.44 (0.86-2.39) 
 
 
Table III. Health and functional status of Participants. SD=standard deviation; OR=odds ratio; SEM=standard 
error of the mean; w/o=without; Kg=kilograms; ADL= activities of daily living; IADL=instrumental activities of 
daily living; MMSE=mini mental state examination. 
 
No difference between centenarians offspring and controls was found 
both in systolic and diastolic pressure but we have to keep in mind that a 
higher proportion of controls took anti-hypertensive drugs (see Table IX).  
Regarding the multimorbidity index a significantly different distribution 
was observed for the two groups with a lower proportion of centenarians 
offspring with more than two pathologies compared with controls.  
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Table IV. Baseline Characteristics of Participants 
Sociodemographic and 
life-style characteristics 
Centenarians 
offspring, 
n=267 
Offspring of non 
long-lived parents, 
n=107 
p-value* 
OR 
(95% CI) 
Life-style     
Current smoker, n (%) 102 (45.3) 39 (44.8) ns  
Former smoker, n (%) 38 (14.4) 18 (17.0) ns  
Alcohol consumption, n (%) 136 (52.5) 57 (54.8) ns  
Education     
Years, mean (SD), y 11.1 (5.3) 10.1 (4.3) .08  
Higher education, n (%) 130 (49.1) 40 (38.8) .06 1.56 (0.97-2.50) 
Marital Status     
Never married, n (%) 43 (16.2) 2 (1.9)   
Married, n (%) 158 (59.4) 81 (77.1) .01  
Divorced, n (%) 14 (5.3) 3 (2.9)   
Widow/widower, n (%) 51 (19.2) 19 (18.1)   
Anthropometric features     
Weight, Kg, mean (SD) 70.0 (0.7) 74.3 (1.2) .002 0.97 (0.95-0.99) 
Height, m, mean (SD) 1.6 (0.004) 1.6 (0.01) ns  
Waist circumference, cm mean (SD) 91.3 (0.7) 94.3 (1.1) .03 0.98 (0.96-0.99) 
Hip circumference, cm mean (SD) 103.4 (0.7) 104.7 (1.1) ns  
BMI score, Kg/m2, mean (SD) 26.5 (0.3) 28.0 (0.4) .005 0.93 (0.88-0.98) 
BMI>25, n (%) 158 (60.8) 79 (76.0) .01 0.51 (0.30-0.86) 
SBP, mmHg mean (SD) 134.6 (1.1) 135.8 (1.7) ns  
DBP, mmHg mean (SD) 77.9 (0.5) 78.8 (0.9) ns  
Comorbidity Index     
0 diseases 35 (13.5) 8 (7.8)  1 
1-2 diseases 118 (45.6) 37 (36.3) .01 0.68 (0.29-1.62) 
>2 diseases 106 (40.9) 57 (55.9)  0.33 (0.14-0.80) 
 
 
Table IV. Baseline characteristics of  Participants. SD=standard deviation; y=years; BMI=Body mass index; 
SBP=Systolic Blood Pressure; DBP=Diastolic Blood Pressure; * adjusted for age and gender; OR=Odds Ratio; 
CI=confidence interval. 
 
Cognitive and physical performances were reported in Table V. Autonomy 
and self sufficiency in conducting the activity of everyday life was measured 
by ADL and IADL tests in which, although both groups were self-sufficient, 
centenarians offspring obtained a significant higher score than controls. 
Cognitive function and symptoms of depression were assessed by MMSE 
and GDS tests. Even in the case of MMSE, although both groups were not 
cognitive impaired, centenarians offspring obtained a better score than 
controls while the GDS score was not statistically different between the two 
groups. Physical performances were assessed through handgrip strength 
and chair stand tests. Better performances were obtained by centenarians 
offspring in both tests, with a significantly higher value of hand strength 
and a greater proportion of subjects able to perform the chair stand test 
without some aid. 
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Table V. Health and functional status of Participants 
Functional Status 
Centenarians 
offspring, 
n=267 
Offspring of non 
long-lived parents, 
n=107 
p-value* 
OR 
(95% CI)  
Autonomy and self sufficiency     
ADL score, mean (SEM) 5.9 (0.4) 5.7 (0.6) .02 1.52 (1.03-2.26) 
IADL score, mean (SEM) 7.9 (0.4) 7.7 (0.7) .05 1.32 (0.98-1.78) 
Cognitive function     
GDS score, mean (SEM) 3.0 (0.2) 2.7 (0.3) ns 1.04 (0.96-1.14) 
MMSE score, mean (SEM) 27.6 (0.1) 27.1 (0.2) .02 1.17 (1.02-1.35) 
Physical Performance     
Handgrip strength, Kg, mean (SD) 30.1 (0.4) 28.6 (0.6) .03 1.04 (1.00-1.09) 
Ability to perform chair stand,  
n (%) 
249 (96.1) 86 (84.3) <.001 4.76 (2.01-11.30) 
 
 
Table V. Health and functional status of Participants; ADL=Activities of Daily Living, IADL=Instrumental 
Activities of Daily Living; GDS=Geriatric Depression Scale; MMSE=Mini Mental State Examination; 
SEM=standard error of the mean; SD=standard deviation; *adjusted for age and gender; OR=Odds Ratio; 
CI=confidence interval 
 
Moreover disability assessment was evaluated by a test developed by S. 
Nagi as described in Materials and Methods. This test allows to evaluate if a 
person was capable to do things of normal everyday life in an indipendent 
manner or by using several aids. 
 
 
Table VI. Disability assessment of Participants 
Disability Assessment 
 
Centenarian‘s 
offspring, 
n=266 
Offspring of non 
long-lived parents, 
n=107 
p-value* OR (95%CI)  
Is the patient able to?     
 Read a newspaper w/o glasses, n (%) 75 (28.3) 27 (25.7) ns 1.15(0.68-1.93) 
 Clearly recognize the face of someone 4 
meters away w/o glasses, n (%) 
220 (83.3) 88 (83.8) ns 0.95 (0.51-1.76) 
 Distinctly hear what is being said in a 
conversation w/o hearing aid, n (%) 
248 (94.3) 97 (92.4) ns 1.31 (0.53-3.24) 
 Walk about half a kilometer w/o walking 
aid, n (%) 
252 (95.5) 94 (89.5) .02 2.85 (1.16-6.96) 
 Go up and down the stairs w/o anyone‘s 
help, n (%) 
226 (85.3) 75 (73.5) .001 2.89 (1.56-5.16) 
Do the patient use any aid? n (%) 9 (3.4) 10 (9.5) .02 0.33 (0.12-0.87) 
 
 
Table VI. Disability assessment of Participants; * adjusted for age and gender; OR=Odds Ratio; CI=confidence 
interval 
 
Results indicate that no difference was found between centenarians 
offspring and controls concerning the ability of reading, recognize a face and 
hearing without aid while a higher proportion of centenarians offspring was 
able to walk about 500 meters and to go up and down the stairs without aid 
in comparison to controls (p=.02 and p=.002 respectively). Furthermore, a 
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lower proportion of centenarians offspring usually were using aid such as 
cane, chair-wheel, and others (Table VI). 
Summarizing these data it emerges that lower weight, waist circumferences 
and BMI,  as well as higher score in the ADL,  IADL, MMSE  and handgrip 
tests, together with the ability to perform chair stand, to walk 500 meters, 
to climb stairs without aid,  the multi-morbidity index and the use of aids 
were associated with centenarians offspring (Table IV, Table V and Table 
VI).  
In light of these results it was examined whether the anthropometric 
variables (BMI and waist circumference) and life-style habits i.e., smoking, 
education, marital status, could affect the better functional condition 
ascertained in centenarians offspring. To clarify this topic a regression 
analysis adjusted for the above mentioned covariates was performed. 
This analysis indicated that the only variables associated with the condition 
of centenarians offspring  that persist after adjustment were those related 
to better physical performance (hand grip strength,   ability to perform chair 
stand and going up and down the stairs) (table VII). 
 
TableVII.  Functional assessment of Participants 
Health and function 
Centenarians 
offspring, 
n=266 
Offspring of non 
long-lived parents, 
n=107 
p-value2 
OR2 
(95% CI)  
Autonomy and self-sufficiency     
ADL score, mean (SEM) 5.9 (0.4) 5.7 (0.6) ns 1.39 (0.92-2.09) 
Cognitive function     
MMSE score, mean (SEM) 27.6 (0.1) 27.1 (0.2) .08 1.14 (0.98-1.33) 
Functional status     
Handgrip strength, Kg mean (SD) 30.1 (0.4) 28.6 (0.6) .01 1.06 (1.01-1.10) 
Ability to perform chair stand, n (%) 249 (96.1) 86 (84.3) .02 3.13 (1.18-8.30) 
Walk about half a kilometer w/o 
walking aid, n (%) 
252 (95.5) 94 (89.5) .ns 2.13 (0.74-5.89) 
Go up and down the stairs w/o 
anyone‘s help, n (%) 
226 (85.3) 75 (73.5) .005 2.53 (1.32-4.86) 
Do the patient use any aid? n (%) 9 (3.4) 10 (9.5) .06 0.34 (0.11-1.07) 
 
 
TableVII. Functional assessment of Participants; ADL=Activities of Daily Living; MMSE=Mini Mental State 
Examination; SEM=standard error of the mean; SD=standard deviation; 2 adjusted for BMI, waist circumference, 
smoking, education, marital status, age and gender; OR=Odds Ratio; CI=confidence interval.   
 
4.3. Perceived health Status 
Perceived health status was assessed by EQ-5D, EQ-VAS, asking 
participants how they considered their health status and asking them which 
was their attitude towards life. For all asked questions to participants no 
differences were found between centenarians offspring and controls, only 
43 
 
the EQ-VAS was statistically different between the groups with 
centenarians offspring indicating higher self-rated health score than 
controls (p=.05) (Table VIII). 
Table VIII. Perceived health status of Participants 
 Perceived Health Centenarians 
offspring, 
n=266 
Offspring of non 
long-lived parents, 
n=107 
p-value* 
OR 
(95% CI) 
Mobility     
No problems, n (%) 217 (82.2) 78 (74.3) .06 0.58 (0.33-1.03) 
Self-Care     
No problems, n (%) 252 (95.5) 100 (95.2) ns 0.91 (0.30-2.80) 
Usual Activities     
No problems, n (%) 244 (92.4) 92 (87.6) ns 0.53 (0.24-1.17) 
Pain/Discomfort     
No problems, n (%) 140 (53.0) 49 (46.7) ns 0.74 (0.46-1.18) 
Anxiety/Depression     
No problems, n (%) 154 (58.3) 57 (54.3) ns 0.81 (0.51-1.28) 
EQ-VAS     
Mean (SEM) 76.3 (1.0) 72.8 (1.5) .05 1.01 (1.00-1.03) 
How was their health in general     
Good/Very good, n (%) 165 (62.5) 52 (50.0)  1 
Fair, n (%) 69 (26.1) 36 (34.6) .08 0.64 (0.37-1.05) 
Poor/Very poor, n (%) 30 (11.4) 16 (15.4)  0.51 (0.25-1.04) 
How was their attitude 
towards life 
    
Optimistic, n (%) 129 (49.0) 59 (56.7)  1 
Neither optimistic nor 
pessimistic, n (%) 
84 (31.9) 30 (28.8) ns 1.30 (0.79-2.25) 
Pessimistic, n (%) 50 (19.0) 15 (14.4)  1.52 (0.78-2.95)  
Table VIII Perceived health status of Participants; SEM=standard error of the mean; * adjusted for age and 
gender;  OR=Odds Ratio; CI=confidence interval 
 
 
4.4. Pharmacological therapy  
Health status was also assessed evaluating both pharmacological therapy 
and prevalence of diseases in both groups. 
 Regarding pharmacological therapy a significant lower proportion of 
centenarians offspring was under medications than controls, and moreover 
among those taking drugs, centenarians offspring took a significantly lower 
number of medicines. Additionally the kind of drug used by participants was 
evaluated in order to know the most common diseases affecting the studied 
population. Results showed that a significant lower prevalence of 
centenarians offspring were under both cardiovascular, hypotensive and 
lipid-lowering therapy compared with controls. It is interesting to highlight 
that  the percentage  of centenarians offspring taking lipid-lowering drugs 
was half of that of controls. After adjusting for covariates all the considered 
parameters continued to be associated with offspring status except for 
cardiovascular therapy (data not shown). These differences were observed 
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both in males and in females (data not shown). No statistical significant 
differences between the two groups were found concerning the antidiabetic 
therapy even if a lower prevalence was observed in centenarian‘s offspring 
compared to controls (5.6 vs 9.4%). (Table IX) 
Table IX. Pharmacological status of Participants 
Pharmacological Therapy 
Centenarian‘s 
offspring, 
n=266 
Offspring of non 
long-lived parents, 
n=107 
OR 
(95% CI) 
p-value* 
Number of prescribed medicines, 
mean (SD) 
2.7 (0.1) 4.3 (0.2) 0.75 (0.67-0.84) <.001 
Subjects taking drugs, n (%) 208 (78.5) 98 (93.3) 0.25 (0.11-0.58) .001 
Cardiovascular Therapy, n (%) 54 (20.2) 36 (34.0) 0.52 (0.31-0.87) .01 
Hypotensive Therapy, n (%) 107 (40.1) 68 (64.2) 0.37 (0.23-0.61) <.001 
Antidiabetic Therapy, n (%) 15 (5.6) 10 (9.4) 0.57 (0.24-1.33) .19 
Lipid-lowering Therapy, n (%) 47 (17.6) 41 (38.7) 0.33 (0.20-0.55) <.001 
 
 
Table IX. Pharmacological status of Participants; SD=standard deviation; * adjusted for age and gender; OR=Odds 
Ratio; CI=confidence interval. 
 
4.5. Prevalence of past and current diseases 
Table X and table XI provide the number of prevalence case of past 
and present age-related diseases for centenarian‘s offspring and offspring of 
non long-lived parents. With regard to pathologies occurred in the past, it 
was found that centenarian‘s offspring had a 58% lower prevalence of 
myocardial infarction (p=.049), a 80% lower prevalence of stroke, cerebral 
thrombosis/haemorrhage (p=.011),  and a 49 % lower prevalence of cancer 
(p=.046) than offspring of non long lived parents. Centenarian‘s offspring 
also displayed lower prevalence of benign tumour even if it did not reach 
statistical significance (Table X).  
 
Table X. Prevalence of  past pathologies 
Disease or Condition 
Centenarians 
Offspring 
Offspring of non 
long-lived parents 
Prevalence 
Odds Ratio 
(95% C.I.) 
p-value* 
 N n (%) N n (%)   
Past Pathologies       
Pneumonia 265 
 
65 (24.5) 
 
105 
 
22 (21.0) 
 
1.21 (0.70-2.10) 
 
.500 
 
Myocardial Infarction 265 
 
12 (4.5) 
 
105 
 
12 (11.4) 
 
0.42 (0.18-0.99) 
 
.049 
 
Stroke, cerebral thrombosis, 
hemorrhage 
264 
 
4 (1.5) 
 
104 
 
8 (7.7) 
 
0.20 (0.06-0.70) 
 
.011 
 Cancer 265 
 
26 (9.8) 
 
105 
 
18 (17.1) 
 
0.51 (0.27-0.99) 
 
.046 
 
Benign Tumor 266 
 
11 (4.1) 
 
105 
 
10 (9.5) 
 
0.42 (0.17-1.03) 
 
.057 
 
Hip fracture 265 
 
5 (1.9) 
 
105 
 
4 (3.8) 
 
0.48 (0.12-1.85) 
 
.287 
 
Spinal collapse 265 
 
8 (3.0) 
 
105 
 
6 (5.7) 
 
0.47 (0.16-1.41) 
 
.178 
 
 
 
* adjusted for age and gender; CI=confidence interval. 
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With regard to pathologies that affected the patients at the time of 
the interview, was found that centenarian‘s offspring had a 46% lower 
prevalence of irregular heart rhythm (p=.05), a 62% lower prevalence of 
hypertension (p=.001) and a 51% lower prevalence of osteoporosis (p=.03) 
than offspring of non long lived parents.  
A lower prevalence of heart failure, COPD, hyperthyroidism, 
hypercholesterolemia, chronic renal insufficiency and cancer were observed 
in centenarian‘s offspring compared with offspring of non long lived parents 
but these differences did not reach statistical significance. No significant 
differences between centenarian‘s offspring and controls were found 
regarding the other pathologies (both past and present) including diabetes.  
 
Table XI. Prevalence of pathologies 
Disease or Condition 
Centenarians 
Offspring 
Offspring of non 
long-lived parents 
Prevalence 
Odds Ratio 
(95% CI) 
p-value* 
 N n (%) N n (%)   
Current Pathologies       
Heart disease       
Heart failure 265 2 (0.8) 
 
105 
 
4 (3.8) 
 
0.23 (0.04-1.28) 
 
.092 
 
Irregular heart rhythm 265 
 
29 (10.9) 
 
106 
 
20 (18.9) 
 
0.54 (0.23-1.00) 
 
.050 
 
Angina Pectoris 264 
 
8 (3.0) 
 
105 
 
4 (3.8) 
 
0.95 (0.28-3.28) 
 
.937 
 
Vascular System       
Hypertension 265 
 
107 (40.4) 
 
106 
 
67 (63.2) 
 
0.38 (0.23-0.62) 
 
.001 
 
Venus insufficiency in legs 264 
 
56 (21.2) 
 
106 
 
23 (31.7) 
 
0.89 (0.51-1.57) 
 
.701 
 
Obstructive Arteriopathy 265 
 
7 (2.6) 
 
105 
 
3 (2.9) 
 
0.82 (0.20-3.30) 
 
.782 
 
Respiratory system       
COPD 265 
 
9 (3.4) 
 
105 
 
9 (8.6) 
 
0.38 (0.14-1.00) 
 
.052 
 
Asthma 265 
 
9 (3.4) 
 
105 
 
7 (6.7) 
 
0.58 (0.20-1.64) 
 
.303 
 
Nervous System       
Depression/Anxiety 265 
 
41 (15.5) 
 
105 
 
22 (21.0) 
 
0.66 (0.37-1.20) 
 
.173 
 
Endocrine System       
Diabetes 265 
 
26 (9.8) 
 
105 
 
12 (11.4) 
 
0.91 (0.44-1.90) 
 
.800 
 
Hyperthyroidism 265 
 
3 (1.1) 
 
105 
 
4 (3.8) 
 
0.23 (0.05-1.06) 
 
.060 
 
Hypothyroidism 265 
 
25 (9.4) 
 
105 
 
8 (7.6) 
 
1.06 (0.45-2.49) 
 
.894 
 
Osteoporosis 265 
 
44(16.6) 
 
105 
 
24 (22.9) 
 
0.49 (0.27-0.92) 
 
.026 
 
Hyperurichemia 265 
 
19 (7.2) 
 
105 
 
5 (4.8) 
 
1.55 (0.56-4.34) 
 
.401 
 
Hypercholesterolemia 265 
 
91 (34.3) 
 
105 
 
44 (41.9) 
 
0.63 (0.39-1.02) 
 
 .062 
 
Artrosis 265 
 
120 (45.3) 
 
105 
 
51 (48.6) 
 
0.82 (0.51-1.30) 
 
.395 
 
Chronic renal insufficiency 265 
 
3 (1.1) 
 
105 
 
5 (4.8) 
 
0.24 (0.05-1.06) 
 
.059 
 
Cancer 265 
 
1 (0.4) 
 
105 
 
3 (2.9) 
 
0.13 (0.01-1.28) 
 
.081 
 
Other diseases# 263 
 
85 (32.3) 
 
106 
 
52 (49.1) 
 
0.51 (0.32-0.82) 
 
.005 
 
 
 
Table XI. Prevalence of pathologies; * adjusted for age and gender; COPD= chronic obstructive pulmonary disease; 
CI=confidence interval; #comprised the following conditions: prostatic hypertrophy; cataract and glaucoma; 
gastritis; hiatus hernia and cholelithiasis; allergies; hemicrania, haemorrhoids, etc. 
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4.6.  Assessment of biochemical parameters and pro and anti-inflammatory 
mediators 
The principal bio-hematochemical parameters were determined in 
centenarian‘s offspring and offspring of non long-lived parents. Although 
lower levels of uric acid, of calcium, of IgA and IgG were found in 
centenarians offspring compared to offspring of non long-lived parents all 
the values were within the reference values (table VII). Regarding the lipid 
profile it was observed that even adjusting for lipid-lowering therapy 
centenarians offspring showed a higher level of triglycerides and a lower 
level of HDL cholesterol different from expected. 
 
Table XII. Hematochemical parameters of the study population 
 
Parameters (reference values) 
Centenarians 
offspring, 
n=248 
Offspring of non 
long-lived parents, 
n=91 
p-value* 
Glucose Profile    
Glycemia, mg/dl (65-110), mean (SD) 93.4 (29.9) 95.7 (27.4) ns 
Insulin, IU/ml, mean (SD) 12.0 (9.6) 11.5 (6.5) ns 
HOMA-IR, mean (SD) 2.9 (2.8) 2.8 (2.2) ns 
Lipid Profile**    
Total Cholesterol, mg/dl (120-220), mean (SD) 203.9 (40.3) 194.5 (33.4) ns 
Triglycerides, mg/dl (40-170), mean (SD) 128.3 (66.2) 120.0 (57.3) .05 
HDL-Cholesterol, mg/dl (40-80), mean (SD) 55.4 (21.1) 60.0 (20.0) .02 
Urea, mg/dl (16-60), mean (SD) 40.8 (15.3) 39.0 (11.9) ns 
Creatinine, mg/dl (0.6-1.2), mean (SD) 0.8 (0.2) 0.9 (0.2) ns 
Uric Acid, mg/dl, (2.5-7.5), mean (SD) 4.9 (1.4) 5.3 (1.4) .05 
Albumine, g/dl (3.5-5.0), mean (SD) 4.0 (0.7) 4.0 (0.6) ns 
Direct Bilirubin, mg/dl (0-0.2), mean (SD) 0.1 (0.1) 0.1 (0.1) ns 
Total Bilirubin, mg/dl (0.2-1.2), mean (SD) 0.6 (0.3) 0.6 (0.4) ns 
Total Proteins, g/dl (6.6-8.7), mean (SD) 7.1 (0.8) 7.2 (0.7) ns 
AST, UI/l (10-45), mean (SD) 19.2 (7.8) 20.1 (7.0) ns 
ALT, UI/l (10-43), mean (SD) 13.9 (11.2) 14.7 (9.5) ns 
GGTS2, UI/l (7-33), mean (SD) 25.6 (25.0) 28.2 (32.3) ns 
ALP, UI/l (<170), mean (SD) 71.7 (45.6) 72.5 (31.7) ns 
Calcium, mg/dl (8-10.4), mean (SD) 8.7 (0.9) 9.0 (0.8) .001 
Ferrum, g/dl (70-175), mean (SD) 97.8 (30.4) 99.0 (37.0) ns 
IgA, mg/dl (90-400), mean (SD) 251.2 (123.6) 305.6 (164.3) .002 
IgG, mg/dl (800-1800), mean (SD) 1,133.0 (658.5) 1,256.9 (444.4) <.001 
IgM, mg/dl (60-280), mean (SD) 123.1 (177.7) 115.5 (103.2) ns 
 
 
Table XII. Data were expressed as mean with standatd deviation (SD) in parenthesis.*adjusted for age and 
gender;** adjusted for age, gender and lipid-lowering therapy; HOMA-IR= Homeostasis Model of Assessment - 
Insulin Resistance; HDL=high density lipoprotein AST=aspartate aminotransferase; ALT=alanine 
aminotransferase; GGTS=gamma glutamyl transferase; ALP=alkaline phosphatase; 
 
The inflammatory status was also determined in both groups by the 
determination of the most important pro and anti-inflammatory mediators. 
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Surprisingly no differences were found between the two groups regarding 
both pro and anti-inflammatory mediators whereas significantly lower IGF-
1 levels were found in centenarians offspring compared to offspring of non 
long lived parents (Table XIII).  
 
Table XIII. Pro and anti-inflammatory mediators of the studied population 
Pro and anti-inflammatory 
mediators  (reference value) 
Centenarians 
offspring, 
n=266 
mean (SEM) 
Offspring of non 
long-lived parents, 
n=107 
mean (SEM) 
p-value* 
Pro-inflammatory mediators    
hs-CRP, (<1 mg/L) 2.6 (0.2) 2.8 (0.3) ns 
A-SAA, g/ml# 4.2 (0.1) 4.0 (0.2) ns 
TNF-pg/ml# 2.1 (0.1) 2.2 (0.2) ns 
IL-6, pg/ml# 2.9 (0.06) 3.0 (0.09) ns 
Resistin, ng/ml# 2.2 (0.04) 2.2 (0.06) ns 
IGF-1, ng/ml 115.7 (2.7) 134.0 (4.5) .001 
Leptin, ng/ml# 2.5 (0.08) 2.7 (0.1) ns 
Anti-inflammatory mediators    
IL-10, pg/ml# 0.9 (.08) 1.0 (0.1) ns 
TGF-1, ng/ml# 1.5 (0.4) 1.5 (0.7) ns 
Adiponectin, g/ml# 3.3 (0.08) 3.4 (0.1) ns 
 
 
Table XIII. Data were expressed as mean with standard error of the mean (SEM) in parenthesis; *adjusted for age 
and gender; #log transformed; hs-CRP=high sensitivity C reactive protein; A-SAA=serum amyloid A; TNF-
alpha=Tumor necrosis factor alpha; IL-6=interleukin 6; IGF-1=insulin growth factor-1; IL-10=interleukin 10; TGF-
beta1=Transforming growth factor beta 1; SEM=standard error of the mean. 
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4.7. White blood cell count and immunophenotype analysis 
Blood cell count was determined in centenarians offspring and offspring of 
non long-lived parents. As reported in Table IX all the values were in the 
normal range although an increase of monocytes (percentage) and of 
basophils (cells, 103/mmc) was found in control group compared with 
centenarians offspring. 
 
Table XIV. Blood cell count in centenarians offspring and offspring of non long-
lived parents 
Blood count (reference values) 
Centenarians 
offspring, 
n=248 
Offspring of non 
long-lived parents, 
n=91 
p-value 
 Mean (SD) Mean (SD)  
Leucocytes (4.2-9.0)    
cells, 103/mmc,  6.2 (1.4) 6.2 (1.9) ns 
Neutrophils    
% (40.0-74.0) 56.4 (7.7) 57.2 (8.4) ns 
cells, 103/mmc, (1.7-6.7) 3.6 (1.0) 3.7 (1.7) ns 
Lymphocytes    
% (19.0-48.0) 31.6 (7.6) 30.0 (7.0) ns 
cells, 103/mmc, (0.8-4.3) 2.0 (0.9) 2.2 (3.6) ns 
Monocytes    
% (3.0-9.0) 6.0 (1.5) 6.5 (1.7) .03 
cells, 103/mmc, (0.1-0.8) 0.4 (0.1) 0.4 (0.5) ns 
Eosinophils    
% (0.0-6.0) 3.0 (1.9) 3.3 (1.7) ns 
cells, 103/mmc, (0.0-0.6) 0.2 (0.1) 0.2 (0.1) ns 
Basophils    
% (0.0-1.5) 0.5 (0.3) 0.6 (0.3) ns 
cells, 103/mmc,  (0.0-0.1) 0.03 (0.02) 0.04 (0.03) .04 
 
 
SD = Standard deviation 
 
Moreover the principal lymphocyte subsets were analyzed in centenarians 
offspring and offspring of non long lived parents.  All data were age and 
gender adjusted. 
The percentage and absolute number of T and B lymphocytes were not 
different between centenarians offspring and controls while CD16+CD56+ 
natural killer cells were significantly higher in centenarian‘s offspring 
compared to offspring of non long lived parents (both percentage and 
absolute number) (Table XV). 
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Table XV. Percentage and absolute number of T, B lymphocytes and of natural killer cells in 
centenarian‘s offspring and offspring of non long lived parents 
Centenarian's Offspring, 
n=248
Offspring of non long lived 
parents, n=91
p-value
Lymphocyte subpopulations median (25th-75th) median(25th-75th)
T lymphocytes, CD3+
percentage, % 67.20 (60.69-73.16) 68.99 (61.51-75.76) .013
absolute number, cells/l 1208.14 (969.33-1502.40) 1138.95 (916.00-1453.17) .427
B lymphocytes, CD19+
percentage, % 7.42 (5.49-9.91) 7.68 (5.72-10.23) .488
absolute number, cells/l 135.02 (97.47-194.66) 132.75 (87.89-190.22) .553
Natural Killer cells, CD16+CD56+
percentage, % 12.00 (7.98-17.74) 11.80 (6.76-16.03) .041
absolute number, cells/l 219.80 (136.25-345.73) 190.47 (110.58-306.18) .013  
Table XV. Data were expressed as median of percentage and absolute number (/l blood)  with 25th-75th percentiles 
in parenthesis. P-value were obtained by regression analysis. Significant differences are highlighted in bold. 
 
Helper and cytotoxic T lymphocytes (both percentage and absolute number) 
as well as the CD4/CD8 ratio did not change between centenarians offspring 
and controls (as reported in Table XVI).  
 
Table XVI. Percentage and absolute number of helper and cytotoxic T lymphocytes and the CD4/CD8 
ratio in centenarian‘s offspring and offspring of non long lived parents 
Centenarian's Offspring, 
n=248
Offspring of non long lived 
parents, n=91
p-value
Lymphocyte subpopulations median (25th-75th) median(25th-75th)
Helper T lymphocytes, CD4+
percentage, % 63.37 (54.44-72.11) 62.86 (55.83-70.21) .803
absolute number, cells/l 729.44 (549.54-983.98) 735.24 (549.47-870.53) .534
Cytotoxic T lymphocytes, CD8+
percentage, % 23.07 (19.05-31.90) 26.50 (20.10-33.66) .248
absolute number, cells/l 279.82 (197.31-422.83) 302.20 (210.48-414.40) .930
CD4:CD8 ratio 2.70 (1.79-3.67) 2.44 (1.73-3.43) .509  
Table XVI. Data were expressed as median of percentage and absolute number (/l blood)  with 25th-75th 
percentiles in parenthesis. P-value were obtained by regression analysis.  
 
Using a combination of surface markers such as CD28 in combination with 
CD95 and CCR7 in combination with CD45RA it has been possible to 
distinguish different lymphocyte subpopulations both inside the helper and 
cytotoxic T lymphocytes compartment. In particular CD28 and CD95 
allowed us to identify cells with naïve, activated/memory, and effector 
phenotype while CCR7 and CD45RA enabled us to distinguish cells with 
naïve, central memory, effector memory and terminally differentiated 
phenotype. 
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Table XVII. Percentage and absolute number of lymphocyte subsets within the helper compartment 
in centenarian‘s offspring and offspring of non long lived parents 
Centenarian's Offspring, 
n=248
Offspring of non long lived 
parents, n=91
p-value
Lymphocyte subpopulations median(25th-75th) median (25th-75th)
Naïve, CD28+/CD95-
percentage, % 39.59 (27.79-49.75) 35.40 (24.09-48.28) .473
absolute number, cells/l 267.37 (171.00-453.10) 250.70 (154.62-400.01) .469
Memory/Activated, CD28+/CD95+
percentage, % 52.00 (41.98-62.31) 51.32 (43.56-66.13) .412
absolute number, cells/l 368.82 (274.48-488.56) 379.15 (269.09-504.56) .648
Effector memory, CD28-/CD95+
percentage, % 4.72 (1.70-9.93) 3.36 (1.18-9.96) .845
absolute number, cells/l 35.96 (12.07-78.40) 22.21 (9.63-65.40) .287
Total CD28+
percentage, % 94.23 (88.09-97.23) 95.36 (89.06-97.63) .839
absolute number, cells/l 697.56 (485.70-888.60) 663.66 (494.97-834.38) .808
Total CD28-
percentage, % 5.61 (2.31-12.19) 4.09 (1.47-10.08) .489
absolute number, cells/l 43.20 (16.00-91.26) 26.48 (11.75-68.29) .195  
Table XVII. Data were expressed as median of percentage and absolute number (/l blood)  with 25th-75th 
percentiles in parenthesis. P-value were obtained by regression analysis. Significant differences are highlighted in 
bold. 
 
Both in the CD4+ and  CD8+ T cells compartment the lymphocyte subsets 
identified by CD28 and CD95 did not change between the two groups (table 
XVII and table XVIII). The only interesting observation was that the naïve 
CD8+CD28+CD95- T cells were higher in centenarians offspring than in 
control subjects although not statistically significant.  
 
Table XVIII. Percentage and absolute number of lymphocyte subsets within the cytotoxic 
compartment in centenarian‘s offspring and offspring of non long lived parents 
Centenarian's Offspring, 
n=248
Offspring of non long lived 
parents, n=91
p-value
Lymphocyte subpopulations median(25th-75th) median(25th-75th)
Naïve, CD28+/CD95-
percentage, % 16.60 (9.18-26.82) 11.00 (5.52-21.65) .094
absolute number, cells/l 43.27 (24.50-78.40) 35.37 (18.77-63.39) .088
Memory/Activated, CD28+/CD95+
percentage, % 36.07 (26.79-50.51) 37.00 (22.37-50.56) .710
absolute number, cells/l 101.62 (65.70-151.94) 100.20 (64.76-141.21) .854
Effector memory, CD28-/CD95+
percentage, % 37.10 (23.16-53.91) 41.09 (25.33-58.71) .304
absolute number, cells/l 95.57 (54.31-184.09) 111.63 (61.80-205.03) .954
Total CD28+
percentage, % 57.93 (41.10-74.10) 52.90 (37.06-72.03) .177
absolute number, cells/l 157.54 (108.56-214.62) 141.75 (107.95-201.70) .453
Total CD28-
percentage, % 42.68 (28.12-58.65) 47.10 (31.90-64.55) .254
absolute number, cells/l 112.11 (59.78-203.22) 134.46 (70.16-229.84) .798  
Table XVIII. Data were expressed as median of percentage and absolute number (/l blood)  with 25th-75th 
percentiles in parenthesis. P-value were obtained by regression analysis. Significant differences are highlighted in 
bold. 
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When other markers such as CCR7 and CD45RA were considered statistical 
significant differences between the two groups appeared. 
In particular, in the helper  compartment an increase of  central memory  
and concomitantly a decrease of terminally differentiated helper T 
lymphocytes was observed in centenarian‘s offspring compared to controls 
while naïve T cells did not change (Table XIX). 
 
Table XIX. Percentage and absolute number of lymphocyte subsets within the helper compartment in 
centenarian‘s offspring and offspring of non long lived parents 
Centenarian's Offspring, 
n=248
Offspring of non long lived 
parents, n=91
p-value
Lymphocyte subpopulations median(25th-75th) median (25th-75th)
Naïve, CD45RA+/CCR7+
percentage, % 24.91 (17.89-34.62) 22.30 (15.92-32.40) .153
absolute number, cells/l 185.65 (106.08-310.50) 160.90 (100.50-248.50) .119
Central Memory, CD45RA-/CCR7+
percentage, % 16.98 (9.68-25.72) 13.10 (6.31-19.78) <.001
absolute number, cells/l 127.45 (62.13-204.45) 92.18 (37.76-153.15) <.001
Effector memory, CD45RA-/CCR7-
percentage, % 41.58 (29.62-50.23) 45.07 (34.46-56.74) .004
absolute number, cells/l 287.62 (204.60-385.65) 320.81 (234.07-402.88) .184
Terminally differentiated, CD45RA+/CCR7-
percentage, % 11.07 (6.03-16.79) 13.25 (7.08-18.90) .006
absolute number, cells/l 74.20 (40.20-131.34) 86.18 (47.81-151.29) .046  
Table XIX. Data were expressed as median of percentage and absolute number (/l blood)  with 25th-75th 
percentiles in parenthesis. P-value were obtained by regression analysis. Significant differences are highlighted in 
bold. 
 
In the cytotoxic compartment an increase of central memory  (only 
absolute number) and naïve cytotoxic T lymphocytes were observed in 
centenarian‘s offspring compared with offspring of non long lived parents 
while effector memory and terminally differentiated CD8+ T lymphocytes  
did not change between the two groups as reported in Table XX. 
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Table XX. Percentage and absolute number of lymphocyte subsets within the cytotoxic compartment 
in centenarian‘s offspring and offspring of non long lived parents 
Centenarian's Offspring, 
n=248
Offspring of non long lived 
parents, n=91
p-value
Lymphocyte subpopulations median(25th-75th) median(25th-75th)
Naïve, CD45RA+/CCR7+
percentage, % 15.27 (9.78-23.04) 12.14 (7.28-18.73) .021
absolute number, cells/l 45.76 (23.35-70.10) 36.34 (19.15-54.74) .037
Central Memory, CD45RA-/CCR7+
percentage, % 6.49 (3.06-10.98) 5.12 (2.61-10.37) .088
absolute number, cells/l 17.88 (8.46-33.75) 13.48 (8.00-28.29) .033
Effector memory, CD45RA-/CCR7-
percentage, % 38.99 (30.13-51.72) 40.51 (29.82-50.05) .905
absolute number, cells/l 104.12 (72.31-172.47) 117.67 (76.42-170.99) .927
Terminally differentiated, CD45RA+/CCR7-
percentage, % 33.23 (18.96-46.22) 38.12 (22.25-50.79) .133
absolute number, cells/l 88.48 (45.52-159.16) 107.99 (46.82-189.08) .398  
Table XX. Data were expressed as median of percentage and absolute number (/l blood)  with 25th-75th percentiles 
in parenthesis. P-value were obtained by regression analysis. Significant differences are highlighted in bold. 
53 
 
 
4.8. Immunophenotype analysis in relation to the CMV seropositivity 
 
Human cytomegalovirus (HCMV) is a member of a distinct, widely 
distributed subgroup of   herpesviruses. A large portion of humanity 
harbors this virus and its seroprevalence increases with age, ranging from 
40–50% in 18–24-years old to 90% in 75–80-years old subjects. The human 
CMV induces a widespread infection whose effects depend on the efficacy of 
immune surveillance; in immunocompetent host the infection usually 
develops without morbid symptoms resulting in a latent infection. 
HCMV infections are characterized by a dynamic, life-long interaction in 
which host immune responses, particularly of T cells, restrain viral 
replication and prevent disease but do not eliminate the virus or preclude 
transmission. It was estimated that the total of the HCMV-specific T cell 
responses in seropositive subjects were enormous, 10% on average of both 
the CD4 and CD8 memory compartments in blood and it is possible to 
speculate that it may increase in aged people. Human aging is characterized 
by expanded and altered adaptive immune responses to human CMV 
(HCMV) particularly of cytotoxic CD28- T cells. The age-dependent 
expansions of CD8+CD28- T-cells, mostly positive for pro-inflammatory 
cytokines and including the majority of CMV-epitope-specific cells indicate 
that a major force able to drive a chronic pro-inflammatory state observed 
during aging may be represented by persistent viral infections like CMV. In 
light of these observations and because of HCMV infection can cause 
substantial perturbations in T cell subsets particularly in the elderly 
population, the seropositivity to the human Cytomegalovirus (HCMV) was 
evaluated in all the subjects recruited. It was found that 91.0% of the 
centenarian‘s offspring and 94.1% of offspring of non long-lived parents were 
CMV seropositive (not significant) (Table XXI). 
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Table XXI. CMV seropositivity 
Centenarians 
offspring,
n=245
Offspring of non 
long-lived parents, 
n=101
p-value
CMV positivity, n (%) 223 (91.0) 95 (94.1) ns
 
CMV=Cytomegalovirus 
 
Despite this we wanted to answer the question if the CMV infection could 
modify the lymphocyte subsets in a different manner in centenarians 
offspring and in controls.  
Results indicate that T cell count  was  significantly higher within CMV-
seropositive centenarian‘s offspring compared with the CMV negative 
centenarians offspring, but it was not different within  offspring of non long-
lived parents. CMV infection seems not to be associated with a major 
alteration in the size of the CD4+ T cell pool both in centenarian‘s offspring 
and in offspring of non long-lived parents, but clear effects were observed on 
the CD8+ T cells. In fact, CD8+ T cell count increased both in centenarian‘s 
offspring and in offspring of non long-lived parents. This increase was of 
47% and 80% higher in centenarian‘s offspring and in offspring of non long-
lived parents respectively, compared with CMV uninfected subjects. 
Additionally this finding have implications for the CD4:CD8 ratio. Indeed, 
the CD4:CD8 ratio was about 27% (in centenarian‘s offspring) and about 
56% (in offspring of non long lived-parents) lower within CMV-seropositive 
subject compared with uninfected groups (Table XXII).  
 
Table XXII. Absolute number of lymphocytes, T lymphocyte subsets in centenarian‘s offspring and 
offspring of non long lived parents 
CMV- CMV+ CMV- CMV+
(n=22) (n=223) p value (n=6) (n=95) p value
Lymphocyte 1.60 (1.26-2.19) 1.80 (1.58-2.20) ns 1.05 (1.30-1.60) 1.70 (1.44-2.09) ns
T cells, CD3
+
0.90 (0.73-1.49) 1.21 (0.97-1.23) .002 1.13 (1.08-1.14) 1.14 (0.93-1.40) ns
CD4
+
 T cells 0.63 (0.50-0.86) 0.74 (0.55-0.97) .27 0.88 (0.70-1.16) 0.73 (0.54-0.86) .16
CD8
+
 T cells 0.19 (0.11-0.25) 0.28 (0.20-0.39) <.001 0.17 (0.15-0.25) 0.31 (0.21-0.41) .03
CD4/CD8 ratio 3.59 (2.59-6.63) 2.61 (1.80-3.64) .005 5.55 (5.47-5.95) 2.43 (1.71-3.43) .005
Offspring of non long-lived parentsCentenarians Offspring
 
Table XXII Data were expressed as median of absolute number (X103/l) with 25th-75th percentiles in parenthesis. 
Significant differences are highlighted in bold. Statistical analysis was performed by the Mann-Whitney U 
nonparametric test. 
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Regarding the helper compartment, CMV infection is strongly associated 
with the expansion of CD4+CD28- T cells in centenarian‘s offspring but not 
in offspring of non long lived parents compared with uninfected subjects. 
On the contrary, CMV infection is associated with about a 50% decrease of 
CD45RA+CCR7+ naïve CD4+ T cells in offspring of non long-lived parents 
but not in centenarian‘s offspring (Table XXIII). Moreover CMV positive 
centenarians offspring showed a higher number of naïve CD4+ T cells 
(CD45RA+CCR7+) compared to CMV positive controls (p=0.04) (figure V).  
 
Table XXIII. Absolute number of T lymphocyte subsets within the helper compartment (CD4+) in 
centenarian‘s offspring and offspring of non long lived parents 
CMV- CMV+ CMV- CMV+
(n=22) (n=223) p value (n=6) (n=95) p value
CD28
+
0.62 (0.51-0.81) 0.70 (0.47-0.87) ns 0.86 (0.71-0.89) 0.66 (0.49-0.82) ns
CD28
-
0.006 (0.004-0.01) 0.05 (0.02-0.09) <.001 0.01 (0.005-0.02) 0.03 (0.01-0.07) ns
CD45RA
+
CCR7
+
0.17 (0.10-0.27) 0.18 (0.10-0.30) ns 0.28 (0.28-0.30) 0.15 (0.09-0.22) .01
CD45RA
+
CCR7
- 0.06 (0.04-0.11) 0.08 (0.04-0.13) ns 0.13 (0.11-0.15) 0.08 (0.04-0.15) ns
Offspring of non long lived parentsCentenarian's Offspring
 
Table XXIII Data were expressed as median of absolute number (X103/l) with 25th-75th percentiles in parenthesis. 
Absolute number of helper T lymphocyte subsets i.e., naïve (CD28+ and CD45RA+CCR7+) effector (CD28-) and 
terminally differentiated (CD45RA+CCR7-). Significant differences are highlighted in bold. Statistical analysis was 
performed by the Mann-Whitney U nonparametric test. 
 
Considering the cytotoxic compartment CMV seropositive subjects resulted 
strongly associated with the CD8+CD28- T cells expansion (quite similar in 
magnitude) both in centenarian‘s offspring and in offspring of non long-lived 
parents compared with uninfected subjects. CMV seropositivity seemed not to 
modify the CD28+ and CD45RA+CCR7+ naïve CD8+ T cells both in centenarian‘s 
offspring and in offspring of non long lived parents. However CMV positive 
centenarians offspring showed a higher number of naïve (CD45RA+CCR7+)  CD8+ T 
cells compared with CMV positive controls. 
Furthermore, CMV presence increased CD45RA+CCR7- CD8+ T cells (terminally 
differentiated effector cells) more than two fold in centenarians offspring and of 
about four fold in offspring of non long lived parents compared with CMV negative 
subjects (Table XXIV). 
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Table XXIV. Absolute number of T lymphocyte subsets within the cytotoxic compartment (CD8+) in 
centenarian‘s offspring and offspring of non long lived parents  
CMV- CMV+ CMV- CMV+
(n=22) (n=223) p value (n=6) (n=95) p value
CD28
+ 0.13 (0.08-0.16) 0.16 (0.11-0.21) ns 0.14 (0.14-0.15) 0.14 (0.10-0.20) ns
CD28- 0.03 (0.01-0.07) 0.12 (0.06-0.20) <.001 0.03 (0.02-0.06) 0.15 (0.08-0.23) .01
CD45RA
+
CCR7
+ 0.03 (0.02-0.05) 0.04 (0.02-0.07) ns 0.02 (0.01-0.04) 0.03 (0.02-0.05) ns
CD45RA
+
CCR7
-
0.04 (0.02-0.06) 0.09 (0.05-0.14) <.001 0.02 (0.02-0.04) 0.11 (0.05-0.19) .02
Offspring of non long lived parentsCentenarian's Offspring
 
Table XXIV Data were expressed as median of absolute number (X103/l) with 25th-75th percentiles in parenthesis. 
Absolute number of cytotoxic T lymphocyte subsets i.e. naïve (CD28+ and CD45RA+CCR7+) effector (CD28-) and 
terminally differentiated (CD45RA+CCR7-). Significant differences are highlighted in bold. Statistical analysis was 
performed by the Mann-Whitney U nonparametric test. 
 
The lymphocytes subsets that were differently altered in the two groups in the 
presence of the CMV infection are reported in Figure V. 
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Figure V. Lymphocyte subsets and CMV status in the studied population 
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Figure V. Effect of CMV seropositivity on the frequency of CD3+ T lymphocytes, cytotoxic and helper lymphocyte 
subsets as well as CD4/CD8 ratio. Box plots show the absolute count (median, 25th and 75th percentiles, range) of 
the lymphocyte subsets. CD3+ T lymphocytes (A), cytotoxic CD8+ T lymphocytes (B), CD4/CD8 ratio (C); naïve (D) 
(CD45RA+CCR7+) and effector  (E) (CD28-) T helper lymphocytes; naïve (F), effector (G) (CD28-) and terminally 
differentiated (H) (CD45RA+CCR7-) cytotoxic T lymphocytes are shown.  
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5. Discussion 
The aim of this work was to study the health, functional, inflammatory and 
immunological status of a group of centenarians offspring and offspring of 
non long-lived parents because of a plethora of literature data indicated that 
offspring of long-lived parents undergoes a better aging in terms of a lower 
prevalence of age-associated diseases (hypertension, cardiovascular disease 
and diabetes) and of a survival advantage regarding all causes, cancer and 
coronary heart disease-specific mortality. 
It is of great importance to remember that the two groups of subjects 
studied show the same age, they were in their seventies and therefore they 
do not represent an extreme aging phenotype. Moreover the most of the 
recruited subjects could be considered healthy as evidenced by the 
hematochemical analysis in the ranges of normality (Table XII and Table 
XIV). 
 
5.1. Anthropometric and functional status 
With aging significant quantitative and qualitative changes occur in the 
body composition: intra abdominal fat tends to increase and subcutaneous 
fat on the limbs tends to decrease. In this study some intriguing findings 
emerge from the analysis of anthropometric features. Centenarian offspring 
showed a significantly lower BMI, weight and waist circumference 
compared with controls (Table IV). These results are of great importance 
because the decrease of body fat, particularly visceral adiposity, has been 
shown to extend life span and slow age-associated changes in several animal 
species including rodents and non human primates (Hadley et al., 2001). On 
the contrary an increase in body fat and BMI have been associated with 
insulin resistance (Paolisso et al., 2000) and increased risk for diabetes 
(Chan et al., 1994), heart disease (Willett et al., 1995) and metabolic 
disorders. The metabolic disorders including dyslipidemias, hypertension, 
and insulin resistance (Vega, 2001), could be less prevalent among the 
offspring of centenarians. In offspring of non long-lived parents the 
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contemporary presence of higher weight and BMI may worsen or highlight a 
hidden metabolic problem that could emerge with increasing age.  
A great number of cross-sectional and longitudinal studies also indicate that 
weight gain and increased BMI, particularly obesity, contribute to decline in 
walking and body transfer ability. In light of this another exciting finding 
emerging from this study is that centenarians offspring appear to be more 
functionally fit than their age-matched controls (Table V and Table VI). 
Particularly hand grip strength, ability to perform chair stand and go up 
and down the stairs are associated with centenarians offspring status even 
after adjusting for age, gender, smoking, education, marital status, BMI and 
waist circumference (Table VII) indicating that not only life-style and 
anthropometric features but also genetic factors or multiple comorbidities 
may play a role in increasing the susceptibility to mobility loss. Evidence 
indicates that a poor performance in chair stand tests and loss of muscle 
strength are associated with adverse health outcomes in older persons 
(Cooper R et al., 2010 Cesari et al., 2006). 
 
5.2. Health status 
Considering the pharmacological therapy and prevalence of diseases it is 
interesting to note that centenarians offspring used fewer medications than 
controls, particularly those for cardiovascular diseases, hypertension and 
hypercholesterolemia (Table IX). Data about the lipid lowering therapy and 
those about the prevalence of hypercholesterolemia seems to indicate  that 
about a half of centenarians offspring suffering of hypercholesterolemia is 
not medically treated. The discrepancy could be explained by the fact that 
these subjects suffer of a type of hypercholesterolemia that may be treated 
modifying life-style and nutrition habits. Moreover the data regarding the 
lipid profile indicate that centenarians offspring have a higher triglycerides 
and lower HDL cholesterol levels compared with controls (Table XII) . This 
apparent discrepancy could be explained by the fact that controls take a 
significantly higher number of lipid-lowering agents (Table IX). On the 
contrary there were no statistical significant differences regarding the use of 
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anti-diabetic medicine in line with the fact that also the proportion of 
subjects with diabetes was not different between the groups (Table IX and 
Table XI).  
The decreased prevalence for age-related diseases in the offspring of 
centenarians is consistent with other research suggesting that long-lived 
parents have long-lived children. Prior studies suggest that both parents 
contribute to the heritability of life expectancy (Brand et al., 2006). 
Intriguingly this study showed that centenarians offspring have had in their 
past fewer episodes of myocardial infarction, stroke, cerebral thrombosis 
and of cancer than offspring of non long-lived parents. Furthermore a lower 
prevalence of irregular heart rhythm, hypertension and osteoporosis was 
found in centenarians offspring compared with controls as already observed 
in other populations (Dellara et al., 2003; Dellara et al 2004a; Dellara et al.,  
2004b). The lower prevalence of hypertension, a recognized risk factor for 
stroke and heart attack, observed in centenarians offspring may protect 
them from the development of cardiovascular diseases. Weight loss, smoking 
cessation, increased physical activity and stress management may also help 
in controlling the blood pressure. The lack of differences for benign tumor, 
heart failure, diabetes, COPD, thyroid diseases, hypercholesterolemia and 
chronic renal insufficiency may be a function of the sample size, the choice 
of the controls, or it may be that families with exceptional longevity do not 
have differential susceptibility to these diseases. 
Finally environmental factors, such as diet, were not taken into account in 
this analysis and might explain an important component of the observed 
differences.  
 
5.3. Inflammatory status 
A chronic low grade inflammatory status is a major feature of the aging 
process contributing to the development of a different pathological 
conditions (De Martinis et al., 2005; De Martinis et al., 2006). This peculiar 
inflammatory activity, leading to long-term tissue damage has been found to 
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be related to mortality risk from all causes in older persons (Bruunsgaard et 
al., 2001).  
Plasma levels of some pro and anti inflammatory mediators were evaluated 
in centenarians offspring and offspring of non long-lived parents. 
Interestingly parameters related to systemic inflammation are not different 
between centenarians offspring and controls. The higher proportion of 
controls taking medication may explain this result or more simply it is 
plausible  that differences between the two groups regarding the parameters 
measured could appear later in life with increasing age. Moreover the level 
of IGF-1 was also assessed. Intriguingly centenarians offspring show lower 
levels of IGF-1 compared with controls. 
Low IGF-1 concentrations have been associated with sarcopenia and seem to 
predict cardiovascular mortality. Remarkably centenarians offspring, 
although having lower levels of IGF1 compared with controls, do not show 
the typical negative aspects related to a low IGF-1 such as loss of mass 
muscle power and cardiovascular diseases but, on the contrary they 
appeared to be more functionally fit (Table V, VI and VII) and seem to have 
a lower or postponed onset of cardiovascular diseases in comparison to 
controls (Table X and XI). This finding could be explained by the fact that 
low concentration of IGF-1 in offspring of centenarians could represent a 
constitutive trait inherited from the centenarian parent, known to have this 
peculiar characteristic but able to postpone the onset of main age related 
diseases reaching extreme lifespan. In humans there is evidence that 
subjects with decreased plasma IGF-I levels preserved insulin action 
compared with aged subjects, thus indicating that an efficient insulin 
response has an impact on human longevity (Paolisso G, et al., 1997 
Paolisso et al., 2000). Moreover, it could be hypothesized that the decrease 
in plasma IGF-I observed in long-lived subjects might minimize the 
generalized mitogenic stimulus to tissues and contribute to the reduction in 
age-related pathologies due to the effect of IGF-I on cellular replication. This 
hormone is in fact linked to the development of several diseases, such as 
cancer (Wang et al., 1998), but the local expression (bioavailability) of IGF-I 
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may be an important factor contributing to the maintenance of normal 
tissue function. The inherently lower IGF-1 found in centenarians offspring 
could also explain, at least in part, the lower prevalence of cancer observed 
in centenarians offspring compared to controls.  
In conclusion ccentenarians offspring appeared to be more fit and healthier 
than controls as could be inferred by the fact that they were leaner, more 
functionally active, unless pharmacologically treated and with a lower 
number of diseases affecting them as summarized in Table XXV. 
 
Table XXV. Summary of the significant findings 
Principal significant findings 
Centenarians 
offspring 
Offspring of non 
long-lived parents 
Anthropometric features   
Weight, Kg Lower Higher 
Waist circumference, cm Lower Higher 
Body Mass Index, Kg/m2 Lower Higher 
Functional status   
Handgrip strength, kg Higher Lower 
Subjects able to perform chair stand Higher Lower 
Subjects able to go up and down the stairs w/o aid Higher Lower 
Pharmacological Therapy   
Mean number of medicines assumed Lower Higher 
Number of subjects taking drugs Lower Higher 
Subjects taking hypotensive drugs Lower Higher 
Subjects taking lipid-lowering drugs Lower Higher 
Diseases   
Past    
Myocardial Infarction Lower Higher 
Stroke, cerebral thrombosis Lower Higher 
Cancer Lower Higher 
Present    
Irregular heart failure Lower Higher 
Hypertension Lower Higher 
Osteoporosis   
Presence of >2 pathologies or conditions Lower Higher 
Cytokines and Hormones   
IGF-1, ng/ml Lower Higher 
 
 
IGF-1=insulin like growth factor. 
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5.4. Immune System 
An Immunophenotype staining was performed to evaluate the principal 
lymphocyte subsets in centenarians offspring and controls. Most of the 
lymphocyte subset does not change between the two groups. This is an 
expected result because of the main alterations in the B and T cell pool have 
been observed with increasing age. However some interesting findings 
emerge from this study. Significant results are summarized in Table XXVI. 
Centenarians offspring have higher CD16+CD56+ NK cells (both percentage 
and absolute number). This subset of NK cells is highly cytotoxic compared 
with CD56- cells. Moreover through the expression of  CD16 on their surface 
this subset is able to mediate the antibody-dependent cellular cytotoxicity 
(ADCC). Natural Killer cells represent the first line of defense against 
infections and developing malignancies. In humans it has been shown that 
NK cell cytotoxicity is well preserved in centenarians and that an increase 
in the actual number of NK cells can be observed in healthy aging ( 
Franceschi et al., 1995; Sansoni et al., 1993). In disease states however, age-
associated alterations in NK cell kinetics and function have been reported 
and include diminished proliferation rates (Zhang et al., 2007), association 
with higher incidences of infection (Ogata et al., 1997), onset of 
atherosclerosis (Bruunsgaard et al., 2001), and increased susceptibility to 
nutritional deficiencies (Ravaglia et al., 2000). Hence, the increase of NK 
cells found in centenarians offspring could protect them against a variety of 
infection and tumors.  
Considering the acquired immunity, helper and cytotoxic T lymphocytes are 
not different between centenarians offspring and controls. An increase of 
central memory (CD45RA-CCR7+) helper (both percentage and absolute 
number) and cytotoxic (only absolute number) T lymphocytes was found in 
centenarians offspring compared with controls. These memory T helper and 
cytotoxic cells respond faster and with enhanced effector function compared 
to naïve cells and carry out their effector function by early production of 
cytokines such as IFNand IL4 or by helping B cells enhancing germinal 
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center reactions. Additionally by activating DC, memory CD4 T cells could 
enhance priming of CD8 T cells and, by the release of granzyme B and 
perforin, they could kill infected cells (MacLeod, 2009). The rise of central 
memory T cells in centenarians offspring is an interesting aspect that will 
require further and more in depth studies. On the contrary terminally 
differentiated helper T lymphocytes (CD45RA+CCR7-) are lower in 
centenarians offspring compared to offspring of non long lived parents. 
These cells are able to mediate effector functions, they are at their late stage 
of differentiation and had a poor proliferative capability. The presence of 
these cells is usually observed in particular settings like CMV or HIV 
infections although their role remains unknown to date. 
Moreover another remarkable finding is the increase of naïve cytotoxic T 
lymphocytes in centenarians offspring in comparison with controls 
rendering the former  more capable to respond to new antigens. It is likely 
that age-related morphological changes occurring in the thymus together 
with other factors, could be less pronounced in centenarians offspring with 
respect to controls (Aspinall et al., 2000). The age-associated reduction in 
naïve T cells and accumulation of CD45RA+ terminally-differentiated 
effector memory T cells, are a hallmark features of immunosenescence, 
believed to contribute to the weakened immune status observed in the 
elderly.  
5.4.1. Immune system and CMV 
Cytomegalovirus is a ubiquitous herpesvirus and infection is so common 
that studies of lymphocyte phenotype and function are commonly 
undertaken in predominantly CMV- seropositive cohorts. In our population 
the prevalence of CMV reaches about 95% in control subjects.  
Comparing CMV positive centenarians offspring and offspring of non long-
lived parents with their CMV negative donors, a different effects of the CMV 
positivity on lymphocyte subsets were observed in the two groups. 
Particularly our data showed a marked effect of CMV infection in increasing 
CD8+  T cells of greater extent in offspring of non long lived parents 
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reflecting in a more pronounced decrease of the CD4/CD8 ratio in the 
control group compared to centenarians offspring. 
It is remarkable to note that, unexpectedly, the presence of CMV induces a 
great expansion of CD4+CD28- T cells in centenarians offspring but not in 
controls on the contrary it decreased naïve helper T cells count in controls 
but not in centenarians offspring. Moreover CMV enormously increased 
CD8+CD28- T cells in a similar manner in the two groups while it increased 
to a greater degree the effector CD45RA+CCR7- CD8+ T lymphocytes in 
controls compared with centenarians offspring. Surprisingly a change of 
naive CD8+ T cells was not observed between CMV negative and positive 
donors in both groups. The differences observed in the magnitude of the 
change of lymphocyte subsets between the two groups may have different 
reasons/origins such as viral reactivation or, for example, the time of 
primary infection. In disagreement with findings observed by 
Derhovanessian et al., in the population studied, changes driven by CMV 
seropositivity occur both in centenarians offspring and in offspring of non 
long-lived subjects but they are different in magnitude. 
Due to a higher prevalence of CMV in the population, a major limit of this 
part of the study is that numerically different groups were compared. 
 
Table XXVI. Summary of the immunological significant findings 
Immunological features Centenarians offspring 
Offspring of non long-
lived parents 
Natural killer cells Increase Decrease 
T Cytotoxic compartment   
Central memory cytotoxic T lymphocytes, 
(CD45RA-CCR7+) 
Increase Decrease 
Naïve cytotoxic T lymphocytes,  
(CD45RA-CCR7+) 
Increase Decrease 
T Helper  compartment   
Central memory helper T lymphocytes, 
(CD45RA-CCR7+) 
Increase Decrease 
Terminally differentiated helper T 
lymphocytes, (CD45RA+CCR7-) 
Decrease Increase 
Prevalence of CMV not change not change 
 CMV- CMV+ CMV- CMV+ 
CD3+ T lymphocytes  ↓ ↑ not change not change 
CD8+ T lymphocytes ↓↓ ↑↑ ↓↓↓ ↑↑↑ 
CD4/CD8 ratio ↑ ↓ ↑↑ ↓↓ 
Effector helper  T lymphocytes, CD28- ↓↓↓↓ ↑↑↑↑ not change not change 
Naïve helper T lymphocytes, CD4+CD45RA+ not change not change ↑↑ ↓↓ 
Effector cytotoxic  T lymphocytes, CD28- ↓↓↓↓ ↑↑↑↑ ↓↓↓↓ ↑↑↑↑ 
Terminally differentiated cytotoxic T 
lymphocytes, CD45RA+CCR7- 
↓↓↓ ↑↑↑ ↓↓↓↓ ↑↑↑↑ 
 
 
CMV=Cytomegalovirus 
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6. Conclusions and Perspectives 
Data collected and analyzed in this work indicate that centenarians 
offspring seem to be healthier and more functionally fit than offspring of 
non long-lived parents. 
It would be desirable to perform longitudinal studies on this highly selected 
population in order to evaluate the possible changes in the inflammatory 
settings that could emerge later in life. Moreover it would be of great 
interest to follow these subjects over time to verify whether centenarians 
offspring have a survival advantage for all-causes, cancer and 
cardiovascular-specific mortality compared with controls as shown for other 
populations. 
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